WO1989007956A1 - Carbon dioxide detection - Google Patents
Carbon dioxide detection Download PDFInfo
- Publication number
- WO1989007956A1 WO1989007956A1 PCT/US1989/000760 US8900760W WO8907956A1 WO 1989007956 A1 WO1989007956 A1 WO 1989007956A1 US 8900760 W US8900760 W US 8900760W WO 8907956 A1 WO8907956 A1 WO 8907956A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbon dioxide
- detector
- indicator
- housing
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0488—Mouthpieces; Means for guiding, securing or introducing the tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0816—Joints or connectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
- A61M16/0816—Joints or connectors
- A61M16/0841—Joints or connectors for sampling
- A61M16/085—Gas sampling
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
- G01N31/223—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators for investigating presence of specific gases or aerosols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
- A61B5/0836—Measuring rate of CO2 production
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/04—Tracheal tubes
- A61M16/0402—Special features for tracheal tubes not otherwise provided for
- A61M16/0411—Special features for tracheal tubes not otherwise provided for with means for differentiating between oesophageal and tracheal intubation
- A61M2016/0413—Special features for tracheal tubes not otherwise provided for with means for differentiating between oesophageal and tracheal intubation with detectors of CO2 in exhaled gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/43—Composition of exhalation
- A61M2230/432—Composition of exhalation partial CO2 pressure (P-CO2)
Definitions
- the present invention relates to novel, improved methods and apparatus for providing an indication if at least a threshold level of carbon dioxide is present or reached in a gas stream or sample of interest.
- the present invention relates to novel, improved methods and apparatus for ensuring that an airway (or endotracheal) tube is properly placed in the trachea of a patient and not in the patient ' s esophagus.
- the present invention relates to novel, improved methods for increasing the shelf life of detectors used for the purposes identified in the two preceding paragraphs and to the resulting detectors.
- Direct visualisation Direct visualization of the vocal cords and observation as the airway tube passes into the trachea is considered by many the "gold standard" of correct tube placement, and this remains one of the more reliable signs.
- direct visualization is impossible to achieve in certain patients, even in the roost experienced hands, due to a multitude of factors.
- Clinicians and medics are thus often called upon to make “blind” intubations in which the position or condition of the patient is such that the progress of the tube cannot be followed visually. For example, it may be dangerous to immediately move an accident victim, or there may be insufficient lighting where a patient has collapsed at home. "Blind" intubations are performed in the hospitals as well, especially in patients who are overweight or have anatomical abnormalities.
- the problem is more common is inexperienced hands and may be associated with haste, poor lighting, or an individual patient's anatomical abnormality.
- the clinician's view may be obstructed by the advancing tube, by acute angulation of the airway in the back of the patient's throat, or by a loss of depth perception with monocular vision.
- the tube may be inadvertently withdrawn fran the trachea before or during securing of the tube or when moving the patient to the lateral or prone position. Additionally, radiographic studies have shown that flexion or extension of the neck can change tube positions as much as five centimeters, resulting in inadvertent extubation which may well not be observed by the clinician.
- Chest Movement Another commonly relied upon method of confirming tracheal intubation is observation of symmetric bilateral movements of the chest wall during ventilation. Some patients, however, have physical conditions in which ventilation is more than usually dependent on diaphragmatic movement as opposed to chest wall movement. Patients with large breasts, obesity, a barrel chest from lung disease, and other conditions tend to develop rigid chest walls. Chest movement can be difficult to evaluate in these circumstances, making assessment of proper tube position by chest expansion unworkable. More importantly, movement of the chest wall simulating ventilation of the lungs can be seen even with the ventilating tube positioned in the esophagus.
- Presence of Exhaled Tidal Volume This method of confirming tracheal intubation can be uncertain because it is possible to have measurable tidal volumes of air moving in the airway tube during spontaneous respiratory efforts with the esophagus intubated and the trachea obstructed.
- researchers have documented tidal volumes of up to 180 milliliters and peak flows of greater than fifty liters per minute under these circumstances.
- Reservoir Bag Compliance Another practice commonly employed is noting the characteristic feel of the reservoir bag associated with normal lung compliance during inspiration and the presence of expiratory refilling of the bag during hand ventilation. However, compliance varies widely from one person to another and within the s.ame individual at different times. Repeated filling and emptying of the stomach with esophageal ventilation, leading to inflation and deflation of the breathing bag, can also be mistaken for pulmonary ventilation.
- Airway Tube Cuff Maneuvers - With the cuff deflated, the higher pitched sound of air escaping around a tracheal tube, compared to the more guttural sound of leakage around an esophageal tube, has been used as a distinguishing feature. However, with the cuff of an esophageal tube located near the level of the cricoid cartilage, the distinction in air sounds may not exist. Also, palpation of the airway tube cuff in the neck to verify position has been reported to fail, perhaps because the easily distensible esophagus simply balloons outward with an inflated cuff inside it.
- Air Escape - A less commonly performed procedure involves pressing sharply on the chest while listening over the tube opening to detect "a characteristic feel and sound of expelled air.” This procedure is unreliable because of the inability to distinguish between air expelled from the tracheal tube and: (1) air passing through or around an esophageal tube, or (2) esophageal air present from mask ventilation prior to intubation, or (3) air expelled from the nose.
- Tube Condensation Condensation of water vapor in the tube, although less likely with esophageal intubation, can occur and hence is not a reliable sign. Conversely, the absence of condensation normally seen with a tube positioned in the trachea would be reason to look for further proof of correct tube position.
- Pulse Oximetry Although useful in many situations, pulse oximetry may be an untimely indicator of esophageal intubation for several reasons. researchers have noted normal functioning of a ventilator when connected to an esophageal tube. With the vocal cords relaxed, patients were studied after deliberate intubation of both the esophagus and trachea.
- Ventilation into the esophagus also caused some ventilation of the lungs, as evidenced by carbon dioxide recordings obtained from the open tracheal tube.
- This ventilation could significantly slow the onset of oxygen desaturation of the blood after esophageal intubation and could delay recognition of esophageal tube placement until surgery is in progress.
- the practice of preoxygenation of patients prior to intubation can slow the recognition of an improper tube position using pulse oximetry because the patients' blood is highly saturated with oxygen at the start of the surgical procedure.
- End-tidal carbon dioxide measurement offers perhaps the most reliable and simplest determination of proper tube placement. It involves the measurement of carbon dioxide concentration during the respiratory cycle. The reliability of carbon dioxide monitoring is based on the assumption that carbon dioxide can be reliably detected in patients with an intact pulmonary circulation and an intubated trachea whereas no carbon dioxide is present in gases exiting from an esophageal tube. Carbon dioxide can be detected initially with esophageal intubation when carbon dioxide has been forced into the stomach during prior mask ventilation. However, the end-tidal carbon dioxide is low in such cases; the wave pattern is irregular; and the carbon dioxide levels rapidly diminish with repeated ventilation, making it easy to distinguish between carbon dioxide from the trachea and that from the esophagus.
- Ease of use - The device must be easy to connect to the airway tube, require no more than minimal interpretation of the indication, and require no electrical power.
- Sensitive - The device must display an obvious indication of carbon dioxide expired from the lung within thirty seconds.
- the indicator must not give false-positive readings but may show transitory readings from a limited volume of carbon dioxide or other materials from the stomach.
- inexpensive The device should desirably sell for less than $1.00 U.S. in large quantities.
- the device should be designed for single patient use. Clean - The device should be designed to be cleaned during assembly in accordance with ANSI Code 279.2 for tracheal tube connectors and adapters.
- Storable - The device must have a shelf life of twenty-four months prior to use without loss of effectiveness.
- novel devices disclosed herein, and the methods in which they are employed, operate on the principles that: (1) after a few breaths, at most, carbon dioxide will appear in the intubated patient' s exhalations at a threshold level (typically three percent) commensurate with tracheal intubation only if the airway tube has been placed in the patient's trachea and not his or her esophagus, and (2) this end-tidal carbon dioxide in a concentration which equals or exceeds the threshold value can be employed to effect an easily observed change in a characteristic of an appropriate indicator.
- a threshold level typically three percent
- One embodiment of the invention which takes advantage of and can be employed to effect such a change in an indicator characteristic and which operates on the principles just described consists of a molded plastic housing, a reservoir of unreacted indicator solution, a reaction medium (or wick), and a sink for the reacted solution.
- the user pulls an activator tab or lanyard, breaking a reservoir seal and exposing the solution to the reaction medium.
- the solution thereupon immediately begins to wick (or migrate) across the reaction medium toward the sink.
- the clinician then connects the detector to the exposed end of an endotracheal tube just previously placed in the patient's airway.
- a ventilator is then connected to the other end of the detector to complete the patient's breathing circuit.
- any carbon dioxide in the patient's breath over or a three percent or other threshold concentration reversibly hydrates in the indicator solution and brings about a change in the color of the indicator solution migrating across the reaction medium toward the sink. This color change is monitored by the clinician. If the endotracheal tube were misplaced in the esophagus, carbon dioxide trapped in the stomach or the esophagus might cause a color change in the indicator solution on the reaction medium. As the carbon dioxide in the breath decreases, however, and more solution migrates across the medium from the reservoir, the color would tend to change back to its initial hue.
- Another important and representative embodiment of the invention employs a thin body of indicator solution trapped between a housing and a liquid-tight membrane of a material which is permeable to uncharged molecules but not to charged molecules or ions.
- a material which is permeable to uncharged molecules but not to charged molecules or ions.
- Teflon tetrafluoroethylene polymer.
- Carbon dioxide in expired gases flowing through the detector diffuses across the permeable membrane and then undergoes reversible hydration in the indicator solution, generating excess hydrogen (H + ) ions and thus reducing the pH of the solution. This causes the indicator to change color, provided that the concentration of carbon dioxide in the expired gases has reached the threshold level and the pH of the solution has consequently been reduced to a level at which the indicator will change color.
- the indicator tends to revert to its original color. Sustained periodic changes of color are an indication of successful tracheal intubation. If esophageal intubation has instead been achieved, the indicator may change color once or a very few times. Thereafter, however, it will tend to revert to and remain its initial color.
- the membrane employed in detectors constructed as disclosed herein passes only uncharged molecules (in this case carbon dioxide), and not hydrogen ions or other charged particles, the membrane keeps charged particles not attributable to the reversible hydration of carbon dioxide from triggering an indicator color change and thereby perhaps providing a false indication of proper endotracheal tube placement.
- uncharged molecules in this case carbon dioxide
- hydrogen ions or other charged particles the membrane keeps charged particles not attributable to the reversible hydration of carbon dioxide from triggering an indicator color change and thereby perhaps providing a false indication of proper endotracheal tube placement.
- the indicator solutions employed in the practice of the present invention may include an oxidation sensitive constituent such as a carbonic anhydra.se catalyst. If incorporated in the solution, it can prove difficult, and expensive, to keep the oxidation sensitive material from deteriorating over a storage period of acceptable length. However, at least in the case of carbonic anhydrase, the perishable material is also available as a freeze, dried powder and, in that form, can be stored indefinitely without deterioration.
- an oxidation sensitive constituent such as a carbonic anhydra.se catalyst.
- selected components of the indicator solution are therefore supplied in a dry, more stable form and are mixed with the fluid phase of the solution only as the carbon dioxide detector is readied for use.
- This can be accomplished by placing the dry and liquid components of the indicator solution in separate, communicable, detector compartments; rupturing a seal between those compartments to establish communication therebetween when the detector is readied for use; and then shaking the detector to disperse the dry components of the solution (the solute) in the fluid carrier. As this dispersion proceeds, the color of the solution will develop, providing a clear indication to the user of the detector that it is ready to be used.
- the material to be protected can be stored on a wick and a fluid phase containing the remaining constituents of the indicator solution put in a capsule.
- the capsule is loaded in a cavity having fluid communication with the wick.
- the capsule is ruptured; and its contents are transferred to the wick, preferably under pressure.
- the fluid phase of the solution then migrates across the wick, incorporating into the indicator solution the relatively perishable material theretofore separately stored on the wick.
- detectors employing the principles of the present invention are rugged, reliable, and easy to use; and they are sensitive to changes in the concentration of carbon dioxide in the gases being monitored. These detectors are simple to use because they employ easily made connections to an airway (or endotracheal) tube or adapter and to the ho.se of a mechanical ventilator, do not require any electrical connections, and require only minimal interpretation of the indications the device provides.
- Monitoring devices employing the principles of the invention are also safe because they are designed to provide secure connections between the device and the components to which it is attached -- typically, as indicated above, an adapter at the exposed end of the airway tube and one end of the ventilator hose tube. There is consequently little chance that the airway tube will come loose and be lodged in the patient's trachea or interfere with the ventilation of the patient or the administration of anesthetics or other gases, etc. or that the ventilator hose will be detached and pose similar problems.
- monitoring devices employing the principles of the invention have a long shelf life.
- novel monitoring devices disclosed herein is such that they are clean at the end of the manufacturing process, and their design also minimizes the possibility of foreign matter being introduced into the device from the ambient surroundings and subsequently entering a patient's lungs.
- the indicator characteristic will consequently change repeatedly (viz., with each exhalation) if the airway tube is placed in the patient's trachea. In contrast, there will be only a single cycle of change or a very few such cycles if the tube is improperly placed in the patient's esophagus as the expelling of the carbon dioxide from the patient's stomach and esophagus is a very short time phenomenon.
- the change in indicator character indicative of a threshold level of carbon dioxide in the gases being monitored is brought about by the reversible hydration of carbon dioxide in an indicator solution to produce excess hydrogen (H + ) ions and a consequent reduction in the pH of .the indicator solution.
- the reversible hydration of carbon dioxide proceeds slowly; and the hydration is preferably catalyzed -- as with the above-mentioned carbonic anhydrase -- so that the indicator will react fast enough to be acceptable to the medical profession; viz. , provide an indication commensurate only with proper tube placement in 30 seconds or less. Buffering can be employed to alter the threshold concentration of carbon dioxide required to trigger a change in the character of the indicator.
- Another important and related, but more specific, object of the invention resides in the provision of methods and devices in accord with the preceding object which employ: (1) the reversible hydration, in an indicator solution, of carbon dioxide in the gases being monitored to produce excess H + ions and reduce the pH of the solution, and (2) the use of an indicator which changes character (typically color) when the concentration of such ions reduces the pH in a solution containing the indicator to a level commensurate with a threshold level of carbon dioxide to provide an indication that that level of carbon dioxide has been reached in the gases being monitored.
- Another important and primary object of the present invention is the provision of novel, improved methods and devices for ensuring that an airway tube has been placed in the trachea of an intubated patient.
- a related, also primary and important object of the invention resides in the provision of devices and methods as characterized in the preceding object in which the concentration of carbon dioxide in the gases flowing through the airway tube is monitored to insure that the airway tube has been properly placed.
- a related and also important and primary object of the invention is the provision of methods and devices in accord with the preceding object in which the carbon dioxide expired by the patient is monitored in a manner that clearly distinguishes between: (1) the reaching of threshold levels of carbon dioxide due to proper placement of the airway tube in the patient's trachea, and (2) the reaching of that same level due to the presence in the monitored gases of carbon dioxide expelled from the patient's stomach and/or esophagus.
- FIG. 1 is a pictorial view of a supine patient with an airway tube placed in his trachea and connected to a mechanical ventilator by way of a carbon dioxide detector as disclosed herein to confirm tracheal intubation in accord with the principles of the present invention
- FIG. 2 is a perspective view of the carbon dioxide detector with part of the detector casing broken away to show its internal construction
- FIG. 3 is a longitudinal section through the detector
- FIG. 4 is an exploded view of a second form of carbon dioxide detector which embodies, and can be employed in methods embodying, the principles of the present invention
- FIG. 5 is a bottom view of the carbon dioxide detector of FIG. 4;
- FIG. 6 is a longitudinal section through the detector of FIG. 4, taken substantially along line 6-6 of FIG. 5;
- FIG. 7 is a longitudinal section through a third type of carbon dioxide detector which can also be employed in methods embodying the principles of the invention and is designed to have a long shelf life;
- FIG. 8 is a fragment of FIG. 7 to a larger scale
- FIG. 9 is a pictorial view of a fourth type of carbon dioxide detector which employs the principles of the present invention and is also designed to have an extended shelf life;
- FIG. 10 is a longitudinal section through the detector of FIG. 9; and FIG. 11 is a transverse section through that detector.
- novel detectors disclosed herein provide a visual indication, typically by effecting a color change in an appropriate indicator, if the carbon dioxide concentration in a .sample of gases supplied to the detector is at, or above, a threshold level.
- pH sensitive indicators are employed. Among those suitable for the purposes of the present invention are :
- the gases flowing through the monitoring device are substantially devoid of carbon dioxide; and those gases are therefore not capable of causing the indicator to change color or causing it to retain the color it assumes when the pH in its environment is reduced.
- the indicator tends to revert to its original color. Therefore, by contacting aliquots of the indicator solution alternately with exhaled and then inspired breaths, the indicator solution will alternately change color and revert to its orginal color. A sustained series of these color change cycles indicates that the airway tube has been placed in the patient's trachea.
- the presently preferred catalyst is the zinc metalloenzyme, carbonic anhydrase.
- This enzyme has at least three distinct isozymes, which can be obtained from a wide variety of human, other animal, and vegetable sources. Carbonic anhydrase obtained from bovine erythrocytes has proven suitable. However, the catalytic mechanism of the different isozymes of carbonic anhydrase appears to be the s»ame (see Silverman et al. , The Catalytic Mechansim of Carbonic Anhydrase: Implications of a Rate-Limiting Protolysis of Water, 21 Accounts of Chemical Research, The Merican Chemical Society, January, 1988 , pp. 30 et seq.) . Consequently, it is not intended to exclude from the patent coverage sought herein the use of carbonic anhydrase isozymes obtained from other sources -- parsley or spinach, for example -- or synthetic isozymes of the carbonic anhydrase.
- a stabilizer for the catalyst may be required.
- Glycerol and propylene glycol are examples of appropriate stabilizers.
- a preservative will typically be required to protect the carbonic anhydrase enzyme against attack by fungi and bacteria.
- Parabens methyl, propyl, butyl, and ethyl esters of para-hydroxybenzoic acid are suitable for this purpose.
- the selected catalyst can be mixed with the indicator solution.
- the carbonic anhydrase can be provided in the form of a freeze-dried powder, a form in which that enzyme is very stable, and mixed with the indicator solution in which the carbon dioxide is reversibly hydrated only when the carbon dioxide detector is readied for use.
- buffers may be added to the indicator solution, as appropriate.
- These compositions alter the concentration of hydrogen ions required to lower the pH of the solution to the level at which the indicator will change color.
- this parameter one can define the threshold concentration of carbon dioxide required to effect a change in the color of the indicator. This allows one to structure the monitoring device so that: the indicator will change color with each exhalation even if the intubated patient is hyperventilating or the concentration of carbon dioxide in his expired breaths is otherwise relatively low and to otherwise adjust the response of the indicator to specified concentrations of carbon dioxide and define its sensitivity to specified concentrations of carbon dioxide.
- Buffers that have been employed for the foregoing purposes include aqueous solutions of: (1) sodium barbital and HCl, (2) NaHCO 3 , and (3) NaOH.
- FIG. 1 depicts the head 20 and upper body 22 of a supine patient 24 and an airway or endotracheal tube 26 placed in the patient's trachea 28.
- the exposed or outer end 30 of the endotracheal tube 26 is connected by an adapter 32 to a detector 34: (1) embodying the principles of the present invention, and (2) provided to detect threshold levels of carbon dioxide in the breaths exhaled by patient 24.
- the carbon dioxide detecting device 34 is connected in line between endotracheal tube 26 and the hose 36 of a mechanical ventilator (not shown).
- a human's esophagus (identified by reference character 38) lies immediately adjacent the patient's trachea 28.
- an endotracheal tube such as that identified by reference character 26 and introduced through the patient's mouth 40 can easily be placed in esophagus 38 rather than trachea 28, even if care is exercised in placing the tube and the conditions under which the tube is placed are optimal.
- carbon dioxide detector 34 substantially eliminates this hazard, even when an endotracheal tube is placed under adverse conditions or by a less than highly trained or skilled individual, because it provides an unmistakable differentiation between tracheal and esophageal intubation.
- an indicator of the character discussed above changes color each time the patient 24 exhales; and the indicator tends to revert to its original (or initial) color between exhalations. If tracheal intubation has been achieved, these changes in color will continue over an extended period of time.
- carbon dioxide detector 34 includes an elongated, hollow, cylindrical, circularly sectioned housing 42 molded or otherwise fabricated from a clear synthetic polymer such as a polyethylene.
- a typical detector of this character is one and one-half inches long and 15 millimeters in diameter.
- Tabs 49 extend radially and in opposite directions from detector housing 42. Rubber bands (not shown) can be trained over these tabs to ensure that the connections of the monitoring device 34 to the endotracheal tube 26 and ventilation hose 36 are maintained.
- a central section 50 Midway between the end sections 44 and 48 of housing 42 is a central section 50.
- An annular groove 52 is formed in this central section 50 of housing 42, and this groove opens onto the bore 54 through housing 42.
- a cylindrical membrane 56 and circular seals 58 and 60 cooperate with the groove 52 in the central section 50 of housing 42 to define a sealed, annular plenum or cavity 62.
- Seals 58 and 60 have annular recesses 64 and 66 in which the opposite ends 68 and 70 of membrane 56 are seated. The resulting assemblage of that membrane with seals 58 and 60 is installed in housing 42 in spaced relation to the inner end of groove 52 and with seal 60 butting against an internal, annular flange 72 in housing 42.
- the sealed chamber thus provided by the cooperation among housing 42, membrane 56, and circular seals 58 and 60 is filled with an indicator solution of the character described above. This may be done by injecting that solution with a hypodermic needle through a port 74 in detector housing 42.
- the injection port is thereafter sealed in any convenient fashion (sealing may be unnecessary, especially if housing 42 is made from a self-sealing material).
- membrane 56 is preferably fabricated from a liquid-tight material which is permeable to uncharged compounds such as carbon dioxide but impermeable to charged particles such as hydrogen ions. Twelve micrometer thick Teflon is satisfactory.
- the concentration of carbon dioxide in the exhalations flowing through detector 34 is at or above a threshold level, the reversible hydration of the carbon dioxide and the resulting build-up of hydrogen ions in the indicator solution will lower the pH of that solution to a level at which the indicator in the solution will change color. Thereafter, and until the next exhalation of patient 24, the hydration reactions will reverse when carbon dioxide comes out of the indicator solution, decreasing as the concentration of that compound in the detector decreases. This carbon dioxide diffuses across membrane 56 back into the bore 54 through detector 34. As this occurs, the concentration of hydrogen ions in the indicator solution will decrease, the pH of that solution will rise, and the indicator will consequently tend to revert to its original color.
- the indicator in the solution trapped in cavity 62 will change color with a frequency approaching that with which patient 24 breaths. If these reversals in color occur for more than a very few breathing cycles, it can safely and reliably be assumed that tracheal intubation has been achieved. This is because, if esophageal intubation has instead been achieved, indicator color changes will not occur after whatever carbon dioxide might be present has been expelled from the patient' s stomach and esophagus; and this occurs, at the latest, after only a very few exhalations. Thereafter, the indicator will tend to revert to its initial color and will remain the color to which it reverts, clearly indicating to the observer that esophageal rather than tracheal intubation has been achieved.
- detector housing 42 is fabricated from a clear material, the just-described visual indications will be clearly evident to the individual monitoring the placement of airway tube 26.
- Bands of color 78 and 79 shown in exaggerated form in FIG. 3, circle detector housing 42 at locations corresponding to the ends of the cavity 62 in which the indicator solution is trapped.
- One of these bands matches the initial color of the indicator; i.e. , the color the indicator has when the carbon dioxide in the gases being monitored is below the threshold limit required to trigger a color change.
- the other band is matched to the color the indicator has when the threshold concentration is reached and the color change effected.
- Indicia associated with the bands (not shown) identify the association of those bands with the initial and changed colors, respectively. Thus, by merely looking at the indicia associated with the band matched by the indicator, the individual monitoring the detector can ascertain whether carbon dioxide is present in a threshold amount.
- FIGS. 4-6 depict a second carbon dioxide detector 80 which also operates in accord with the principles of the present invention but in a somewhat different manner than the just-described detector 34 does.
- carbon dioxide detector 80 includes a housing or casing 82 having a main, boxlike member 84.
- a lid 86 can be sealed to casing member 84 after the internal components of the detector are installed to isolate the interior 88 of housing 82 from the ambient surroundings. This keeps the casing interior from being contaminated by foreign substances in the surrounding environment.
- Integra bosses 90 and 92 at the opposite ends of main casing member 84 have external and internal tapers 94 and 96 which, like their counterparts 44 and 46 in adapter 34, provide reliable and secure connections between: (1) the carbon dioxide detector 80, and (2) the airway adapter 32 and mechanical ventilator hose 36 to which that detector is attached.
- Supported in parallel, spaced apart recesses 98 and 100 in main casing member 84 are: (1) a reservoir capsule 102 filled with an indicator solution of the character described above, and (2) a member 104 which functions as a sink for the indicator solution. Encapsulation or other packaging is employed to prevent evaporation and to keep the indicator solution from being contaminated.
- Window 114 may be provided by molding main casing member 84 from a clear plastic or by installing a window of such material in a casing member otherwise formed from a different material. Appropriate clear polymers are identified above and hereinafter.
- Wick 112 will typically be fabricated from a conventional, commercially available, non-woven, Nylon paper. Other materials with wicking capabilities may instead be employed; but it is, however, important that the wicking medium not be acidic. Otherwise, it might affect a change in the indicator solution not attributable to the presence of a threshold level of carbon dioxide, consequently keeping the carbon dioxide detector from working properly.
- Member 104 can be made from an absorbent material such as a gauze sponge.
- a lanyard 116 (see FIGS. 4 and 6) is pulled before the connection between detector 80 and endotracheal tube adapter 32 is effected. This ruptures reservoir 102 over a span indicated by reference character 118 in FIG. 4, allowing the indicator solution to flow onto and saturate that end 108 of wick 112 at reservoir 102. If tracheal intubation of patient 24 has been achieved, carbon dioxide in the exhalations flowing through detector 80 in the direction indicated by arrow 120 in FIG. 4 will reversibly hydrate in the indicator solution migrating along wick 112 and effect an indicator color change as discussed above.
- the indicator solution will migrate to the left .along wick 112 as indicated by arrow 122 once it has been released from reservoir 102, typically for a period of approximately fifteen minutes. If tracheal intubation has been achieved, the indicator on wick 112 will tend to revert to its original color between exhalations, a change promoted by air flowing through the detector to the patient and flushing carbon dioxide from the indicator solution as the air traverses detector casing 82. That part of the wick subsumed by the color change will increase with each successive exhalation. This clearly indicates that tracheal intubation has been achieved.
- FIGS. 7 and 8 depict yet another carbon dioxide detector 130 embodying the principles of the present invention.
- This detector resembles the carbon dioxide detector 34 illustrated in FIGS. 2-4 and discussed above. To the extent that this is true, like components of detectors 34 and 130 have been identified by the same reference characters.
- the carbon dioxide detector 130 illustrated in FIGS. 7 and 8 is furthermore like detector 34 in that an indication commensurate with a threshold level of carbon dioxide having been reached in a sample being monitored is produced by: (1) that carbon dioxide diffusing across a permeable membrane and undergoing reversible hydration in an indicator solution behind the membrane, and (2) a consequent generation of an excess of hydrogen ions in the indicator solution to trigger a change in the color of the indicator.
- Indicator 130 does differ in a major respect frcm indicator 34 in that the solute (dry components, typically a pH sensitive indicator and a carbonic anhydrase catalyst) and solvent (typically water plus a buffer) of the indicator solution are not mixed until carbon dioxide detector 130 is readied for use. As discussed above, this is important with respect to the storage life prior to use of the detector because the indicator solution will typically contain one or more constituents which are much more stable in dry form then in aqueous solution.
- solute dry components, typically a pH sensitive indicator and a carbonic anhydrase catalyst
- solvent typically water plus a buffer
- indicator 130 the typically but not necessarily aqueous, fluid phase of the indicator .solution is injected into the sealed cavity 62 behind permeable membrane 56 through injection port 74.
- the remaining constituents of the indicator solution are furnished in a dry form and placed in a compartment 132.
- This compartment lies between a seal 134 located in a depression 135 in the central section 50 of casing 42 and a flexible push tab 136 fixed to that seal.
- a communicating channel 138 is provided through detector housing 42 between sealed compartment 132 and the sealed cavity 62 behind membrane 56.
- FIGS. 9-11 depict a novel carbon dioxide detector 144 which embodies the principles of the invention and which, like the detector 130 illustrated in FIGS. 7 and 8, is designed for increased shelf life.
- detector 144 components of detector 144 which are like those of previously disclosed embodiments of the invention will be identified by the same reference characters. As in the case of carbon dioxide detector 130, detector 144 has an increased shelf life because constituents of the indicator solution such as the above-discussed carbonic anhydrase catalyst are stored in their most stable, dry form until the detector is readied for use.
- the deterioration susceptible component (or components) of the indicator solution are placed on a porous wick 146; and the remaining constituents of the indicator solution 148, including one of the indicators identified above or a comparable one, are confined in a capsule 150.
- an opening 152 is formed in the center section 50 of the detector housing or casing 42 (in this case generally ⁇ -sectioned, see FIG. 11).
- the flanges 154 and 156 of this detector component are seated on end section 48 and shoulder 44 of detector casing 42 at the opposite ends of opening 152.
- Membrane 56 is trapped against the bottom wall 160 of support 158 by a combined lens and actuator support 162. This component fits in a recess 164 in membrane/wick support 158 (see FIG. 10) and is frictionally retained in that recess.
- An aperture 166 is formed through the center section 50 of detector casing 42 opposite membrane 56 . In a manner akin to that discussed above in conj unction with detectors 34 and 130 , this allows carbon dioxide in exhaled breaths or other gases traversing the bore 54 in detector casing 42 to flow into contact with, and migrate through, the permeable membrane.
- the wick 146 which serves as a carrier or support for a carbonic anhydrase catalyst (or other "dry" phase) in the illustrated, representive embodiment of the invention is seated in, and extends at both ends beyond, a recess or enclosed space 168 opening onto the lower side 170 of the lens/actuator support 162 immediately adjacent membrane 56 .
- the membrane therefore traps wick 146 in recess 168.
- Wick 146 of detector 144 will typically be fabricated f rom a 2-4 mil thick, porous Nylon. Other materials may instead be used with the caveat that the material must facilitate the rapid migration of the indicator solution across the wick.
- the capsule 150 containing the liquid or fluid phase of the indicator solution is fabricated from a thermoplastic polymer such as polyvinyl chloride .
- the capsules may conveniently be made by filling an elongated tube of the selected polymer with the solution, heat sealing the tube from edge to edge at intervals therealong, and subsequently separating the thus provided, filled capsules.
- the lens/actuator support 162 has a vertically oriented, integral section 172 with a rectangularly sectioned cavity 174 extending from top to bottom thereof.
- a passage 176 in component 162 provides fluid communication between the bottom end of cavity 174 and that enclosed space 168 in component 162 which houses membrane 146.
- an integral, vertically extending pin 180 with a point or knife edge 182 at its upper end is formed in detector component 162 at the bottom of cavity 174.
- the indicator solution filled capsule 150 is installed in cavity 174 with the lower edge 184 of the capsule resting on the pointed, upper end 182 of pin 180.
- a frictionally retained plunger 186 with an operator-engageable button 188 and an integral, depending main body section 190 configured to match the contour of cavity 174 is installed in the latter above the indicator solution-containing capsule 150.
- the capsule is seated in an arcuate recess 192 in the lower end of the plunger section with the plunger resting on the capsule 190 and thereby restrained against side-to-side movement in the cavity.
- plunger 186 is displaced by button 188 in the direction indicated by arrow 193 in FIG. 10 until detents 194 and 195 at the opposite sides of the plunger main section 190 click into cooperating recesses 196 and 197.
- These recesses are formed in vertically oriented, lens/plunger support component 162 at the opposite sides 198 and 200 of the vertical, rectangularly sectioned cavity 174 in section of that component and toward the upper end of the cavity.
- the cavity surrounding end walls 202 and 204 of section 172 have recesses 206 and 208 at the upper ends thereof.
- the fluid phase of the indicator solution released from capsule 150 by rupturing the latter and pumped through the communicating passage 176 into the cavity 168 in which wick 146 is housed dissolves the "dry" indicator constituent or constituents on that wick as it migrates thereacross. Because of the wicking capabilities of support 146, this occurs within a few seconds, resulting in color being developed in the indicator solution. This development of color clearly indicates to the user of the device that the carrier supported and capsule contained components of the solution have been intimately mixed and that the carbon dioxide detector 144 is therefore ready for use.
- plunger main section 190 the opposite sides 212 and 214 of plunger main section 190 are relieved as with the illustrated, vertically extending slots 216 and 218. These slots allow air to escape from that part 220 of the cavity 174 in lens/plunger support component 162 beneath plunger 186 as the latter is depressed. This ensures that the plunger can readily be fully displaced to the click stop position discussed above.
- At least the lens/plunger supporting component 162 of detector 144 is fabricated from a clear polymer and with an integral, convex lens 210 opposite indicator solution-filled space 168 (see FIGS. 9 and 10) so that the development of color in the indicator solution and subsequent changes in that color can be readily seen by the user of the device.
- This component of carbon dioxide detector 144, as well as the other components of that device may be made from a number of clear, thermoformable polymers -- for example, the styrene-butadiene copolymers marketed by Phillips Petroleum Company under the trade name K-RESIN. It is not essential, in fabricating a carbon dioxide detector of the type illustrated in FIGS.
- the carbon dioxide is reversibly hydrated in the indicator solution to produce excess hydrogen ions and lower the pH of the indicator solution. If the carbon dioxide is at, or reaches, a threshold level, the pH of the solution will decrease to a level capable of triggering an indicator color change and providing a visual indication that the concentration of carbon dioxide is at or has reached the threshold level.
- original and changed colors are clear visual indications of, respectively, the absence and presence of a threshold level of carbon dioxide in gases being sampled and passing through the bore 54 in carbon dioxide detector 144.
- the constituents of the indicator solution will be the following:
- the carrier of the indicator solution be an aqueous one.
- the reversible hydration of carbon dioxide in ethanol is a well-documented phenomenom.
- the use of this compound and other fluids in which the reversible hydration of carbon dioxide can be carried out in the indicator solutions of the present invention is therefore intended to be covered in the appended claims unless expressly excluded therefrom.
- a catalyst preferably a "dry" carbonic anhydrase isozyme or a mixture of such isozymes -- can be added to the indicator solution to increase the speed with which the detector employing the indicator solution reacts to a change in carbon dioxide concentration. Storage of this catalyst and/or other perishable indicator solution constituents is optionally employed to increase the shelf life of the detector.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Methods and apparatus (80) for ascertaining whether there is at least a threshold concentration of carbon dioxide in gases being monitored. Reversible hydration of the carbon dioxide to generate excess hydrogen ions and trigger a color change in pH sensitive indicator (112) is employed in representative embodiments of the invention to provide an indication that the threshold concentration of carbon dioxide is present in the gases. The methods and apparatus may be used to distinguish between tracheal and esophageal intubation of human and other mammalian patients.
Description
CARBON DIOXIDE DETECTION
TECHNICAL FIELD OF THE INVENTION
In one aspect, the present invention relates to novel, improved methods and apparatus for providing an indication if at least a threshold level of carbon dioxide is present or reached in a gas stream or sample of interest. In another, and equally important, aspect, the present invention relates to novel, improved methods and apparatus for ensuring that an airway (or endotracheal) tube is properly placed in the trachea of a patient and not in the patient ' s esophagus. And, in a third and also equally important aspect, the present invention relates to novel, improved methods for increasing the shelf life of detectors used for the purposes identified in the two preceding paragraphs and to the resulting detectors. Medical applications of the invention are of particular importance at the present time, and the principles of the present invention will accordingly be developed primarily with reference to such applications. It is to be understood, however, that this is being done for the sake of convenience and clarity and is not intended to limit the scope of protection sought herein.
BACKGROOND OF THE INVENTION
Just a few decades ago, an unexpected death or serious mishap during surgery was viewed as a tragic but unavoidable event by patients and their families, and by the public at large. Lawsuits were rare, and settlements were modest.
Today, the average patient in reasonable health who enters a hospital fully expects clinicians to provide care with a near-zero risk of complication or death. If a procedure leads to loss of life or major impairment, the damage is no longer regarded as acceptable, especially when it is. thought to be the result of avoidable technical or human failure. These incidents now lead to major malpractice suits against hospitals and physicians.
One of the most important aspects of critical care is the clinician's management of the patient's airway. Typically, this involves placement of an endotracheal (or airway) tube in the trachea of the patient. Oral intubation of the human trachea has become a routine procedure used to maintain a clear airway in most surgical, emergency, and intensive care situations. Intubations are performed in the hospital and in the field by individuals of differing backgrounds and levels of training. Failure to achieve trachea! intubation, resulting in the airway tube being placed in the esophagus and diverting air flow from the lungs, can cause patient complications (morbidity) or death (mortality) and is a continuing source of clinicians' anxiety.
The problem is acute because there are an estimated 18 million surgeries performed under general
anesthesia each year in the United States alone. In addition, one million acute heart attack patients and three million trauma patients are admitted to hospitals each year. Most of these patients require mechanical ventilation and thus require tracheal placement of an airway tube.
In addition, there are other situations, typically in the field, where intubations are performed by paramedics or other individuals with less background and training than is typically found among hospital personnel. Misplacement of airway tubes (unrecognized esophageal intubation) by these individuals also contributes significantly to morbidity and mortality statistics. A review of various anesthesia-related morbidity and mortality statistics indicates that unrecognized esophageal intubation is a problem, even among those members of the medical population specifically trained in the tracheal intubation technique. An analysis of anesthetic accidents reported to the Medical Defense Union of the United Kingdom from 1970-1978 revealed that nearly half of the ca.ses resulting in death or cerebral damage were due to faulty clinical technique. The procedure most often identified as the source of mishap was tracheal intubation with inadvertent esophageal -- rather than tracheal -- tube placement.
Another reviewer of anesthesiat-related medical liability clams in the United Kingdom from 1977 to 1982 listed esophageal intubation as a "main cause" of accidents leading to death or neurologic damage with the largest monetary claims resulting from such mishaps.
An investigation of anesthesia-related deaths in Australia revealed that 69% of these deaths were related to airway mismanagement with esophageal intubation once again identified as a major contributing factor.
In one institution in the United States, unrecognized esophageal intubation was identified as a significant problem in a study of cardiac arrests that had been attributed solely to anesthesia. There were twenty-seven cardiac arrests among 163,240 anesthetic cases over a fifteen year period. Of these twenty-seven cardiac arrests, four were attributed to esophageal intubation.
In the state of Kansas, five malpractice cases involving improper intubation were settled for one million dollars each in 1984-85. Four new cases alleging improper intubation were brought before Kansas courts in the first six months of 1986; at issue were two deaths and two brain-damage cases, all involving patients who were having elective surgeries.
In reviewing malpractice claims brought against anesthesiologists in Washington State from 1971-1982, researchers found that esophageal intubation figured prominently among complications resulting in cardiac arrest, brain damage, and death. Of 192 claims, seven were brought for unrecognized esophageal intubation.
The foregoing makes it clear that a reliable technique for confirming that tracheal intubation has been achieved would be of signal importance to the medical profession. Techniques providing signs which may, in some circumstances, indicate that a successful
tracheal intubation has been accomplished include the following:
Direct visualisation - Direct visualization of the vocal cords and observation as the airway tube passes into the trachea is considered by many the "gold standard" of correct tube placement, and this remains one of the more reliable signs. Unfortunately, direct visualization is impossible to achieve in certain patients, even in the roost experienced hands, due to a multitude of factors. Clinicians and medics are thus often called upon to make "blind" intubations in which the position or condition of the patient is such that the progress of the tube cannot be followed visually. For example, it may be dangerous to immediately move an accident victim, or there may be insufficient lighting where a patient has collapsed at home. "Blind" intubations are performed in the hospitals as well, especially in patients who are overweight or have anatomical abnormalities. The problem is more common is inexperienced hands and may be associated with haste, poor lighting, or an individual patient's anatomical abnormality. Often, the clinician's view may be obstructed by the advancing tube, by acute angulation of the airway in the back of the patient's throat, or by a loss of depth perception with monocular vision.
Even if visualization of the vocal cords and tracheal tube placement has been achieved, the tube may be inadvertently withdrawn fran the trachea before or during securing of the tube or when moving the patient to the lateral or prone position. Additionally, radiographic studies have shown that flexion or extension of the neck can change tube positions as much
as five centimeters, resulting in inadvertent extubation which may well not be observed by the clinician.
Chest Movement - Another commonly relied upon method of confirming tracheal intubation is observation of symmetric bilateral movements of the chest wall during ventilation. Some patients, however, have physical conditions in which ventilation is more than usually dependent on diaphragmatic movement as opposed to chest wall movement. Patients with large breasts, obesity, a barrel chest from lung disease, and other conditions tend to develop rigid chest walls. Chest movement can be difficult to evaluate in these circumstances, making assessment of proper tube position by chest expansion unworkable. More importantly, movement of the chest wall simulating ventilation of the lungs can be seen even with the ventilating tube positioned in the esophagus. Distension of the stomach with air can cause outward movement, mimicking the downward movement of the diaphragm and outward movement of the lower chest; Escape of gas from the .stomach through the esophagus with release of bag compression would allow the diaphragm to fall and would move the lower chest inward, creating the false impression that there is exhalation from the lungs. Confirmation of this phenomenon exists in numerous reports and studies. At least one study demonstrated chest movements "identical to those seen when the lungs were inflated" where, in fact, stomach ventilation had been established through an airway tube intention.ally inserted into the esophagus.
Breath Sounds - The presence of bilateral breath sounds from a stethoscope placed over each of the lungs would seem to be a strong reassurance of proper
tube position based on experience and common sense. However, the literature documents numerous cases involving experienced clinicians where apparently normal breath sounds were present with esophageal ventilation. Air passing through the esophagus has been noted to resemble coarse or tubular breath sounds, and it has been suggested that the combination of esophageal wall oscillation with gas movement and acoustic filtering can produce wheezes similar to the sounds arising from lungs ventilated mechanically or by hand.
Presence of Exhaled Tidal Volume - This method of confirming tracheal intubation can be uncertain because it is possible to have measurable tidal volumes of air moving in the airway tube during spontaneous respiratory efforts with the esophagus intubated and the trachea obstructed. Researchers have documented tidal volumes of up to 180 milliliters and peak flows of greater than fifty liters per minute under these circumstances. Reservoir Bag Compliance - Another practice commonly employed is noting the characteristic feel of the reservoir bag associated with normal lung compliance during inspiration and the presence of expiratory refilling of the bag during hand ventilation. However, compliance varies widely from one person to another and within the s.ame individual at different times. Repeated filling and emptying of the stomach with esophageal ventilation, leading to inflation and deflation of the breathing bag, can also be mistaken for pulmonary ventilation.
Airway Tube Cuff Maneuvers - With the cuff deflated, the higher pitched sound of air escaping around a tracheal tube, compared to the more guttural
sound of leakage around an esophageal tube, has been used as a distinguishing feature. However, with the cuff of an esophageal tube located near the level of the cricoid cartilage, the distinction in air sounds may not exist. Also, palpation of the airway tube cuff in the neck to verify position has been reported to fail, perhaps because the easily distensible esophagus simply balloons outward with an inflated cuff inside it. Air Escape - A less commonly performed procedure involves pressing sharply on the chest while listening over the tube opening to detect "a characteristic feel and sound of expelled air." This procedure is unreliable because of the inability to distinguish between air expelled from the tracheal tube and: (1) air passing through or around an esophageal tube, or (2) esophageal air present from mask ventilation prior to intubation, or (3) air expelled from the nose.
Tube Condensation - Condensation of water vapor in the tube, although less likely with esophageal intubation, can occur and hence is not a reliable sign. Conversely, the absence of condensation normally seen with a tube positioned in the trachea would be reason to look for further proof of correct tube position. Pulse Oximetry - Although useful in many situations, pulse oximetry may be an untimely indicator of esophageal intubation for several reasons. Researchers have noted normal functioning of a ventilator when connected to an esophageal tube. With the vocal cords relaxed, patients were studied after deliberate intubation of both the esophagus and trachea. Ventilation into the esophagus also caused some ventilation of the lungs, as evidenced by carbon dioxide
recordings obtained from the open tracheal tube. This ventilation could significantly slow the onset of oxygen desaturation of the blood after esophageal intubation and could delay recognition of esophageal tube placement until surgery is in progress. Also, the practice of preoxygenation of patients prior to intubation can slow the recognition of an improper tube position using pulse oximetry because the patients' blood is highly saturated with oxygen at the start of the surgical procedure. End-Tidal Carbon Dioxide Measurement -
End-tidal carbon dioxide measurement offers perhaps the most reliable and simplest determination of proper tube placement. It involves the measurement of carbon dioxide concentration during the respiratory cycle. The reliability of carbon dioxide monitoring is based on the assumption that carbon dioxide can be reliably detected in patients with an intact pulmonary circulation and an intubated trachea whereas no carbon dioxide is present in gases exiting from an esophageal tube. Carbon dioxide can be detected initially with esophageal intubation when carbon dioxide has been forced into the stomach during prior mask ventilation. However, the end-tidal carbon dioxide is low in such cases; the wave pattern is irregular; and the carbon dioxide levels rapidly diminish with repeated ventilation, making it easy to distinguish between carbon dioxide from the trachea and that from the esophagus.
The disadvantage of this test is that it takes a relatively expensive monitoring device. Also, this device is too cumbersome for routine use in all settings where it would be needed; and it must be connected to an electrical power source during the intubation procedure.
This is disadvantageous because power may not be available where, or when, intubation is needed.
In short, the position of the airway tube employed to achieve tracheal intubation of a patient and thereby manage his or her airway must be checked on each in.sertion; and there are a large number of tests available to confirm tracheal placement of the tube. Hewever, considerable evidence challenges the relative merits of these heretofore available tests. Also, there has been, up to now, no single device which can or would be used in all situations to detect misplacement of airway tubes in the esophagus. Furthermore, clinical studies have shown that, even with the detection of seemingly proper signs by experienced clinicians, an airway tube may have been placed in the esophagus. Also, a number of the just-discussed techniques for confirming tracheal intubation employ monitoring devices; and those devices each lack one or more of the following attributes, all of which are either required for the monitoring device to be successful or important in obtaining this goal:
Ease of use - The device must be easy to connect to the airway tube, require no more than minimal interpretation of the indication, and require no electrical power.
Sensitive - The device must display an obvious indication of carbon dioxide expired from the lung within thirty seconds.
Reliable - The indicator must not give false-positive readings but may show transitory readings from a limited volume of carbon dioxide or other materials from the stomach.
inexpensive - The device should desirably sell for less than $1.00 U.S. in large quantities.
Disposable - To avoid cross-contamination, the device should be designed for single patient use. Clean - The device should be designed to be cleaned during assembly in accordance with ANSI Code 279.2 for tracheal tube connectors and adapters.
Safe - The device must not allow components to which it is attached to become disconnected or otherwise impede the normal ventilation of the patient.
Rugged - The device must withstand severe stresses without disconnecting from its mating tube.
Storable - The device must have a shelf life of twenty-four months prior to use without loss of effectiveness.
From the foregoing, it can be seen that undiagnosed esophageal intubation figures prominently in anesthesia-related morbidity or mortality and related malpractice suits. The commonly utilized methods of assessing tube position are all unsatisfactory under the circumstances encountered in tracheal tube placement. Expired carbon dioxide measurement is currently the most reliable means under all circumstances of determining proper tube position, but this method suffers from the requirement that an expensive monitoring device be attached to the airway tube before correct placement can be verified. Thus, the usefulness of this procedure in emergency conditions is limited; and it is relegated to formal hospital settings. There is no inexpensive product currently available which provides a simple test for carbon dioxide expired by the patient through the airway tube to verify tracheal tube placement.
SUMMARY OF THE INVENTION
There have now been invented, and disclosed herein, certain new and novel methods and devices which are usable in all known circumstances to provide a positive, reliable indication that tracheal intubation has been achieved.
The novel devices disclosed herein, and the methods in which they are employed, operate on the principles that: (1) after a few breaths, at most, carbon dioxide will appear in the intubated patient' s exhalations at a threshold level (typically three percent) commensurate with tracheal intubation only if the airway tube has been placed in the patient's trachea and not his or her esophagus, and (2) this end-tidal carbon dioxide in a concentration which equals or exceeds the threshold value can be employed to effect an easily observed change in a characteristic of an appropriate indicator. One embodiment of the invention which takes advantage of and can be employed to effect such a change in an indicator characteristic and which operates on the principles just described consists of a molded plastic housing, a reservoir of unreacted indicator solution, a reaction medium (or wick), and a sink for the reacted solution. To prepare the detector for use, the user pulls an activator tab or lanyard, breaking a reservoir seal and exposing the solution to the reaction medium. The solution thereupon immediately begins to wick (or migrate) across the reaction medium toward the sink. The clinician then connects the detector to the exposed end of an endotracheal tube just previously placed in the patient's airway. A ventilator is then connected to
the other end of the detector to complete the patient's breathing circuit. As the ventilator forces air in and out of the endotracheal tube, any carbon dioxide in the patient's breath over or a three percent or other threshold concentration reversibly hydrates in the indicator solution and brings about a change in the color of the indicator solution migrating across the reaction medium toward the sink. This color change is monitored by the clinician. If the endotracheal tube were misplaced in the esophagus, carbon dioxide trapped in the stomach or the esophagus might cause a color change in the indicator solution on the reaction medium. As the carbon dioxide in the breath decreases, however, and more solution migrates across the medium from the reservoir, the color would tend to change back to its initial hue. The continued presence of the unreacted color would warn the clinician that air from the lungs was not being carried by the tube and that the tube may be misplaced. If the tube is properly placed, the newly wicked solution reacts with the carbon dioxide coming from the lungs and quickly and definitely changes color. This detector gives a continuous indication of the presence of carbon dioxide for approximately fifteen minutes after the device's seal is broken.
Another important and representative embodiment of the invention employs a thin body of indicator solution trapped between a housing and a liquid-tight membrane of a material which is permeable to uncharged molecules but not to charged molecules or ions. One such material is Teflon (tetrafluoroethylene polymer). Carbon dioxide in expired gases flowing through the detector diffuses across the permeable
membrane and then undergoes reversible hydration in the indicator solution, generating excess hydrogen (H+) ions and thus reducing the pH of the solution. This causes the indicator to change color, provided that the concentration of carbon dioxide in the expired gases has reached the threshold level and the pH of the solution has consequently been reduced to a level at which the indicator will change color. Thereafter, and between exhalations: the hydration of the carbon dioxide reverses, the carbon dioxide comes out of solution and diffuses back across the membrane, and the indicator tends to revert to its original color. Sustained periodic changes of color are an indication of successful tracheal intubation. If esophageal intubation has instead been achieved, the indicator may change color once or a very few times. Thereafter, however, it will tend to revert to and remain its initial color.
Because the membrane employed in detectors constructed as disclosed herein passes only uncharged molecules (in this case carbon dioxide), and not hydrogen ions or other charged particles, the membrane keeps charged particles not attributable to the reversible hydration of carbon dioxide from triggering an indicator color change and thereby perhaps providing a false indication of proper endotracheal tube placement.
The indicator solutions employed in the practice of the present invention may include an oxidation sensitive constituent such as a carbonic anhydra.se catalyst. If incorporated in the solution, it can prove difficult, and expensive, to keep the oxidation sensitive material from deteriorating over a
storage period of acceptable length. However, at least in the case of carbonic anhydrase, the perishable material is also available as a freeze, dried powder and, in that form, can be stored indefinitely without deterioration.
In yet another and also very important embodiment of the invention, selected components of the indicator solution, such as the just-discussed carbonic anhydrase catalyst, are therefore supplied in a dry, more stable form and are mixed with the fluid phase of the solution only as the carbon dioxide detector is readied for use. This can be accomplished by placing the dry and liquid components of the indicator solution in separate, communicable, detector compartments; rupturing a seal between those compartments to establish communication therebetween when the detector is readied for use; and then shaking the detector to disperse the dry components of the solution (the solute) in the fluid carrier. As this dispersion proceeds, the color of the solution will develop, providing a clear indication to the user of the detector that it is ready to be used.
Alternatively, the material to be protected can be stored on a wick and a fluid phase containing the remaining constituents of the indicator solution put in a capsule. The capsule is loaded in a cavity having fluid communication with the wick. To ready the detector for use, the capsule is ruptured; and its contents are transferred to the wick, preferably under pressure. The fluid phase of the solution then migrates across the wick, incorporating into the indicator solution the relatively perishable material theretofore separately stored on the wick.
Embodiments of the invention of the character just described thus eliminate the above-discussed shelf life problem in a simple yet elegant fashion because the catalyst and any other perishable components are stored in a dry, stable form until the carbon dioxide detector is readied for use.
The foregoing and other embodiments of the invention are simple and inexpensive, and it is therefore practical to dispose of them after a single use.
Due at least in part to their simplicity, detectors employing the principles of the present invention are rugged, reliable, and easy to use; and they are sensitive to changes in the concentration of carbon dioxide in the gases being monitored. These detectors are simple to use because they employ easily made connections to an airway (or endotracheal) tube or adapter and to the ho.se of a mechanical ventilator, do not require any electrical connections, and require only minimal interpretation of the indications the device provides.
These novel devices can be easily monitored--even, for example, in a dimly lit room, using only a pen-sized flashlight. Response times are rapid; changes in the indicator evidencing tracheal placement of the endotracheal tube are forthcoming in 30 seconds or less (4-7 human breaths).
Response times on the order of those just described are desirable as, if they are achieved, monitoring devices of the character disclosed and claimed herein will function reliably to distinguish between tracheal and esophageal intubation even if the intubated patient is hyperventilating and the level of
carbon dioxide in the patient's exhalations is thereby lowered.
Monitoring devices employing the principles of the invention are also safe because they are designed to provide secure connections between the device and the components to which it is attached -- typically, as indicated above, an adapter at the exposed end of the airway tube and one end of the ventilator hose tube. There is consequently little chance that the airway tube will come loose and be lodged in the patient's trachea or interfere with the ventilation of the patient or the administration of anesthetics or other gases, etc. or that the ventilator hose will be detached and pose similar problems. By virtue of the materials from which they are fabricated and the fact that the indicators and associated substances employed in the practice of the preent invention can be provided in stable form and isolated from the ambient surroundings, monitoring devices employing the principles of the invention have a long shelf life.
The design of the novel monitoring devices disclosed herein is such that they are clean at the end of the manufacturing process, and their design also minimizes the possibility of foreign matter being introduced into the device from the ambient surroundings and subsequently entering a patient's lungs.
It is important, in employing the monitoring of carbon dioxide to determine proper airway placement, to distinguish between carbon dioxide expelled from the patient's lungs and carbon dioxide expelled from his or her stomach and esophagus as these anatomical structures may contain enough carbon dioxide to cause the
monitoring device indicator to undergo a change in character and thus provide a potentially false indication of proper airway tube placement. As suggested above, this important distinction is made in accord with the principles of the present invention by employing a reversible indicator -- i.e., one which will change in color (or other observable characteristic) when the threshold concentration of carbon dioxide is reached and revert toward its original color when the carbon dioxide concentration in the gases being monitored decreases to a lower level. The indicator characteristic will consequently change repeatedly (viz., with each exhalation) if the airway tube is placed in the patient's trachea. In contrast, there will be only a single cycle of change or a very few such cycles if the tube is improperly placed in the patient's esophagus as the expelling of the carbon dioxide from the patient's stomach and esophagus is a very short time phenomenon. The change in indicator character indicative of a threshold level of carbon dioxide in the gases being monitored is brought about by the reversible hydration of carbon dioxide in an indicator solution to produce excess hydrogen (H+) ions and a consequent reduction in the pH of .the indicator solution. Also relied on is the dehydration that occurs when the concentration of carbon dioxide in the reaction situs decreases -- during inhalation, for example -- to effect an increase in the pH of the indicator solution and a consequent reversion in the color of that solution to its original color. In particular, it was pointed out above that a sustained series of color changes as just
described can be employed to confirm that intubation of a ventilated patient has been achieved.
The reversible hydration of carbon dioxide proceeds slowly; and the hydration is preferably catalyzed -- as with the above-mentioned carbonic anhydrase -- so that the indicator will react fast enough to be acceptable to the medical profession; viz. , provide an indication commensurate only with proper tube placement in 30 seconds or less. Buffering can be employed to alter the threshold concentration of carbon dioxide required to trigger a change in the character of the indicator.
OBJECTS OF THE INVENTION
From the foregoing it will be apparent to the reader that one important and primary object of the present invention resides in the provision of novel, improved devices and methods for monitoring the concentration of carbon dioxide in a specified environment.
Another important and related, but more specific, object of the invention resides in the provision of methods and devices in accord with the preceding object which employ: (1) the reversible hydration, in an indicator solution, of carbon dioxide in the gases being monitored to produce excess H+ ions and reduce the pH of the solution, and (2) the use of an indicator which changes character (typically color) when the concentration of such ions reduces the pH in a solution containing the indicator to a level commensurate with a threshold level of carbon dioxide to
provide an indication that that level of carbon dioxide has been reached in the gases being monitored.
Another important and primary object of the present invention is the provision of novel, improved methods and devices for ensuring that an airway tube has been placed in the trachea of an intubated patient.
A related, also primary and important object of the invention resides in the provision of devices and methods as characterized in the preceding object in which the concentration of carbon dioxide in the gases flowing through the airway tube is monitored to insure that the airway tube has been properly placed.
A related and also important and primary object of the invention is the provision of methods and devices in accord with the preceding object in which the carbon dioxide expired by the patient is monitored in a manner that clearly distinguishes between: (1) the reaching of threshold levels of carbon dioxide due to proper placement of the airway tube in the patient's trachea, and (2) the reaching of that same level due to the presence in the monitored gases of carbon dioxide expelled from the patient's stomach and/or esophagus.
Other important but more specific objects of the present invention reside in the provision of monitoring devices as described in the preceding objects: which have a rapid response time and are easy to use, sensitive, reliable, sufficiently inexpensive to be disposed of after a single use, and rugged; which will not become detached from the airway tube placed in a patient or otherwise malfunction and impede or interfere with the management of the patient;
which can be stored prior to use for extended periods of time without a loss of effectiveness; in which, in conjunction with the preceding object, sensitive compositions employed in an indicator solution to indicate a threshold level of carbon dioxide in a sample are provided in a dry, stable form and stored in that form until the detector is readied for use; which, in medical applications, provide a clear differentiation between changes in an indicator due to: (1) carbon dioxide expelled from a patient's stomach and/or esophagus (improper placement of the airway tube in the patient's esophagus); which allow the threshold concentration of carbon dioxide required to trigger a change of an indicator characteristic such as color to be easily adjusted; and which are versatile and can be employed in a variety of applications not in the medical field in which the monitoring of carbon dioxide levels can be utilized to advantage.
Other important objects and features and additional advantages of the invention will be apparent to the reader from the foregoing and the appended claims and as the ensuing detailed description and discussion proceeds in conjunction with the accompanying drawing.
BRIEF DESCRIPTION OF THE DRAWING
in the drawing:
FIG. 1 is a pictorial view of a supine patient with an airway tube placed in his trachea and connected to a mechanical ventilator by way of a carbon dioxide
detector as disclosed herein to confirm tracheal intubation in accord with the principles of the present invention;
FIG. 2 is a perspective view of the carbon dioxide detector with part of the detector casing broken away to show its internal construction;
FIG. 3 is a longitudinal section through the detector;
FIG. 4 is an exploded view of a second form of carbon dioxide detector which embodies, and can be employed in methods embodying, the principles of the present invention;
FIG. 5 is a bottom view of the carbon dioxide detector of FIG. 4; FIG. 6 is a longitudinal section through the detector of FIG. 4, taken substantially along line 6-6 of FIG. 5;
FIG. 7 is a longitudinal section through a third type of carbon dioxide detector which can also be employed in methods embodying the principles of the invention and is designed to have a long shelf life;
FIG. 8 is a fragment of FIG. 7 to a larger scale;
FIG. 9 is a pictorial view of a fourth type of carbon dioxide detector which employs the principles of the present invention and is also designed to have an extended shelf life;
FIG. 10 is a longitudinal section through the detector of FIG. 9; and FIG. 11 is a transverse section through that detector.
DETAILED DESCRIPTION OF THE INVENTION
As discussed above, the novel detectors disclosed herein provide a visual indication, typically by effecting a color change in an appropriate indicator, if the carbon dioxide concentration in a .sample of gases supplied to the detector is at, or above, a threshold level. pH sensitive indicators are employed. Among those suitable for the purposes of the present invention are :
Napthal Red Phenol Red Cresol Red m-Cresol Purple Bromothymol Blue
Bromophenol Blue Brilliant Yellow p-Nitrophenol 2 ,5-Dinitrophenol Litmus
Mixtures of the foregoing and/or other indicators may also be employed.
The color changes undergone by all of the foregoing indicators in the face of a decreasing pH are reversible; and the indicator will accordingly tend to revert to its initial color if the pH rises to a level above that triggering the color change. As discussed above, this is an important part of the invention as periodic, exhalation-related color changes can be employed to distinguish proper placement of an airway tube from placement of the tube in the patient ' s esophagus (both placements can result in sufficient carbon dioxide being circulated to the detector to
produce a single or very small number of indicator color changes).
During exhalation, carbon dioxide in the intubated patient's expired breath is reversibly hydrated in the indicator solution, producing excess hydrogen ions. These ions lower the pH of the indicator solution, causing the indicator to change color as discussed above.
During inspiration, the gases flowing through the monitoring device are substantially devoid of carbon dioxide; and those gases are therefore not capable of causing the indicator to change color or causing it to retain the color it assumes when the pH in its environment is reduced. As a consequence, during inspiration, the indicator tends to revert to its original color. Therefore, by contacting aliquots of the indicator solution alternately with exhaled and then inspired breaths, the indicator solution will alternately change color and revert to its orginal color. A sustained series of these color change cycles indicates that the airway tube has been placed in the patient's trachea. In contrast, if esophageal intubation has instead been achieved, there may be one or even a very few color changes; but the solution will thereafter continuously remain the initial color it assumes in the absence of a color change triggering concentration of hydrogen ions. This clearly indicates that the airway tube has erroneously been placed in the patient's esophagus. For example, in those embodiments of the invention employing a body of indicator solution behind a gas permeable membrane, dissolved carbon dioxide will come out of solution and diffuse out through the
membrane during inspiration; and the indicator consequently tends to revert to its initial color. In this type of monitor, therefore, the color of the indicator will change with each inspiration and exhalation if the airway tube is properly placed in the patient' s trachea. If the patient is instead the victim of improper esophageal intubation, there may be one to a few indicator color changes; but the indicator will thereafter tend to revert to and remain its original, unchanged color.
The color changes undergone by Cresol Red are typical. A three percent concentration of carbon dioxide (volume percent based on dry air) will cause this indicator in aqueous solution to change from purple to yellow . In vivo experiments shewed that one to three breaths by pigs would result in sufficient build-up of carbon dioxide in the indicator solution to effect a useful color change of this indicator. Initial color changes occurred in 5-10 seconds and complete color changes in 20-40 seconds.
The reversible hydration resulting in the indicator color change and the subsequent reversion of the indicator to its original color when carbon dioxide is subsequently removed from the reaction site - - both typi-cally relied upon to verify tracheal intubation - - may proceed more slowly than what is believed to be optimal. Consequently, a catalyst is prefer-ably employed to speed up these reactions so that the response time of the detector will be within the limits specified above. Catalysts that one may employ include:
Carbonic Anhydrase NaOCL
Na Selenite Na2SO3 The presently preferred catalyst is the zinc metalloenzyme, carbonic anhydrase. This enzyme has at least three distinct isozymes, which can be obtained from a wide variety of human, other animal, and vegetable sources. Carbonic anhydrase obtained from bovine erythrocytes has proven suitable. However, the catalytic mechanism of the different isozymes of carbonic anhydrase appears to be the s»ame (see Silverman et al. , The Catalytic Mechansim of Carbonic Anhydrase: Implications of a Rate-Limiting Protolysis of Water, 21 Accounts of Chemical Research, The Merican Chemical Society, January, 1988 , pp. 30 et seq.) . Consequently, it is not intended to exclude from the patent coverage sought herein the use of carbonic anhydrase isozymes obtained from other sources -- parsley or spinach, for example -- or synthetic isozymes of the carbonic anhydrase.
Particularly if carbonic anhydrase is employed to catalyze the reversible hydration of carbon dioxide, a stabilizer for the catalyst may be required. Glycerol and propylene glycol are examples of appropriate stabilizers.
Also, a preservative will typically be required to protect the carbonic anhydrase enzyme against attack by fungi and bacteria. Parabens (methyl, propyl, butyl, and ethyl esters of para-hydroxybenzoic acid) are suitable for this purpose.
The selected catalyst can be mixed with the indicator solution.
Alternatively, as discussed above, the carbonic anhydrase can be provided in the form of a freeze-dried powder, a form in which that enzyme is very stable, and mixed with the indicator solution in which the carbon dioxide is reversibly hydrated only when the carbon dioxide detector is readied for use.
Additionally, buffers may be added to the indicator solution, as appropriate. These compositions .alter the concentration of hydrogen ions required to lower the pH of the solution to the level at which the indicator will change color. By thus adjusting this parameter, one can define the threshold concentration of carbon dioxide required to effect a change in the color of the indicator. This allows one to structure the monitoring device so that: the indicator will change color with each exhalation even if the intubated patient is hyperventilating or the concentration of carbon dioxide in his expired breaths is otherwise relatively low and to otherwise adjust the response of the indicator to specified concentrations of carbon dioxide and define its sensitivity to specified concentrations of carbon dioxide.
Buffers that have been employed for the foregoing purposes include aqueous solutions of: (1) sodium barbital and HCl, (2) NaHCO3, and (3) NaOH.
Similar adjustments in sensitivity, response time, etc. can also be obtained by employing a different indicator as the pH and pH range to which pH sensitive indicators respond are typically different. Referring now to the drawing, FIG. 1 depicts the head 20 and upper body 22 of a supine patient 24 and an airway or endotracheal tube 26 placed in the patient's trachea 28. The exposed or outer end 30 of
the endotracheal tube 26 is connected by an adapter 32 to a detector 34: (1) embodying the principles of the present invention, and (2) provided to detect threshold levels of carbon dioxide in the breaths exhaled by patient 24. As is shown in FIG. 1, the carbon dioxide detecting device 34 is connected in line between endotracheal tube 26 and the hose 36 of a mechanical ventilator (not shown).
As is readily apparent from FIG. 1, a human's esophagus (identified by reference character 38) lies immediately adjacent the patient's trachea 28. As a consequence, an endotracheal tube such as that identified by reference character 26 and introduced through the patient's mouth 40 can easily be placed in esophagus 38 rather than trachea 28, even if care is exercised in placing the tube and the conditions under which the tube is placed are optimal. And it was pointed out above that it is often difficult to ascertain by heretofore available techniques whether the endotracheal tube has been properly placed and that undetected esophageal intubation of patients has occurred with astonishing regularity with consequent morbidity and more than occasional mortality.
It was also pointed out above that carbon dioxide detector 34 substantially eliminates this hazard, even when an endotracheal tube is placed under adverse conditions or by a less than highly trained or skilled individual, because it provides an unmistakable differentiation between tracheal and esophageal intubation. In particular, when carbon dioxide monitoring devices of the character shown in FIG. 1 and identified by reference character 34 are utilized, an indicator of the character discussed above changes color
each time the patient 24 exhales; and the indicator tends to revert to its original (or initial) color between exhalations. If tracheal intubation has been achieved, these changes in color will continue over an extended period of time. In contrast, if the endotracheal tube 26 has instead been placed in the patient's esophagus, a reversible color change may occur concomitantly with the patient's first breath, and may continue for a few breaths, because of the presence of carbon dioxide in gases expelled from the patient's esophagus and/or stomach. Thereafter, however, the indicator will tend to revert to and remain its original color, clearly indicating that esophageal as opposed to tracheal intubation has been achieved. Referring now to FIGS. 2 and 3, carbon dioxide detector 34 includes an elongated, hollow, cylindrical, circularly sectioned housing 42 molded or otherwise fabricated from a clear synthetic polymer such as a polyethylene. A typical detector of this character is one and one-half inches long and 15 millimeters in diameter.
An externally tapered shoulder 44 at one end of housing 42 and an internally tapered aperture or recess 46 in the opposite end 40 of that housing, both conforming to ANSI Standard 279.2, respectively accept ventilator hose 36 and endotracheal tube adapter 32 and provide .secure connections between those components and the carbon dioxide detector. This ensures, with a high degree of reliability, that the connections between endotracheal tube 26 and the mechanical ventilator will not be interrupted, a consequence that is to be avoided because of the danger this would pose to the intubated patient.
Tabs 49 extend radially and in opposite directions from detector housing 42. Rubber bands (not shown) can be trained over these tabs to ensure that the connections of the monitoring device 34 to the endotracheal tube 26 and ventilation hose 36 are maintained.
Midway between the end sections 44 and 48 of housing 42 is a central section 50. An annular groove 52 is formed in this central section 50 of housing 42, and this groove opens onto the bore 54 through housing 42.
As is best shown in FIG. 3, a cylindrical membrane 56 and circular seals 58 and 60 cooperate with the groove 52 in the central section 50 of housing 42 to define a sealed, annular plenum or cavity 62. Seals 58 and 60 have annular recesses 64 and 66 in which the opposite ends 68 and 70 of membrane 56 are seated. The resulting assemblage of that membrane with seals 58 and 60 is installed in housing 42 in spaced relation to the inner end of groove 52 and with seal 60 butting against an internal, annular flange 72 in housing 42.
The sealed chamber thus provided by the cooperation among housing 42, membrane 56, and circular seals 58 and 60 is filled with an indicator solution of the character described above. This may be done by injecting that solution with a hypodermic needle through a port 74 in detector housing 42. The injection port is thereafter sealed in any convenient fashion (sealing may be unnecessary, especially if housing 42 is made from a self-sealing material).
As discussed above, membrane 56 is preferably fabricated from a liquid-tight material which is permeable to uncharged compounds such as carbon dioxide
but impermeable to charged particles such as hydrogen ions. Twelve micrometer thick Teflon is satisfactory.
With carbon dioxide detector 34 coupled to and between mechanical ventilator hose 36 and endotracheal tube adapter 32 as shown in FIG. 1, gases exhaled by patient 24 will flow from endotracheal tube 26 through detector 34 in the direction indicated by arrow 76 in FIGS. 2 and 3. Carbon dioxide in the gases exhaled by patient 24 diffuses across membrane 56 into the indicator solution filling cavity 62, this cavity therefore also serving as a reaction chamber. As discussed above, the carbon dioxide reversibly hydrates in the indicator solution to form excess hydrogen ions. If the concentration of carbon dioxide in the exhalations flowing through detector 34 is at or above a threshold level, the reversible hydration of the carbon dioxide and the resulting build-up of hydrogen ions in the indicator solution will lower the pH of that solution to a level at which the indicator in the solution will change color. Thereafter, and until the next exhalation of patient 24, the hydration reactions will reverse when carbon dioxide comes out of the indicator solution, decreasing as the concentration of that compound in the detector decreases. This carbon dioxide diffuses across membrane 56 back into the bore 54 through detector 34. As this occurs, the concentration of hydrogen ions in the indicator solution will decrease, the pH of that solution will rise, and the indicator will consequently tend to revert to its original color.
Thus, the indicator in the solution trapped in cavity 62 will change color with a frequency approaching that with which patient 24 breaths. If these reversals
in color occur for more than a very few breathing cycles, it can safely and reliably be assumed that tracheal intubation has been achieved. This is because, if esophageal intubation has instead been achieved, indicator color changes will not occur after whatever carbon dioxide might be present has been expelled from the patient' s stomach and esophagus; and this occurs, at the latest, after only a very few exhalations. Thereafter, the indicator will tend to revert to its initial color and will remain the color to which it reverts, clearly indicating to the observer that esophageal rather than tracheal intubation has been achieved.
Because detector housing 42 is fabricated from a clear material, the just-described visual indications will be clearly evident to the individual monitoring the placement of airway tube 26.
Bands of color 78 and 79, shown in exaggerated form in FIG. 3, circle detector housing 42 at locations corresponding to the ends of the cavity 62 in which the indicator solution is trapped. One of these bands matches the initial color of the indicator; i.e. , the color the indicator has when the carbon dioxide in the gases being monitored is below the threshold limit required to trigger a color change. The other band is matched to the color the indicator has when the threshold concentration is reached and the color change effected. Indicia associated with the bands (not shown) identify the association of those bands with the initial and changed colors, respectively. Thus, by merely looking at the indicia associated with the band matched by the indicator, the individual monitoring the detector
can ascertain whether carbon dioxide is present in a threshold amount.
In a typical application of the invention employing cresol red as an indicator, one of the bands 78 and 79 will be purple to match the initi.al color of the indicator; and the other will be yellow, matching the color the indicator has when a threshold concentration of carbon dioxide is present or reached. Referring still to the drawing, FIGS. 4-6 depict a second carbon dioxide detector 80 which also operates in accord with the principles of the present invention but in a somewhat different manner than the just-described detector 34 does.
Referring then to the Figures just identified, carbon dioxide detector 80 includes a housing or casing 82 having a main, boxlike member 84. A lid 86 can be sealed to casing member 84 after the internal components of the detector are installed to isolate the interior 88 of housing 82 from the ambient surroundings. This keeps the casing interior from being contaminated by foreign substances in the surrounding environment.
Integra bosses 90 and 92 at the opposite ends of main casing member 84 have external and internal tapers 94 and 96 which, like their counterparts 44 and 46 in adapter 34, provide reliable and secure connections between: (1) the carbon dioxide detector 80, and (2) the airway adapter 32 and mechanical ventilator hose 36 to which that detector is attached. Supported in parallel, spaced apart recesses 98 and 100 in main casing member 84 are: (1) a reservoir capsule 102 filled with an indicator solution of the character described above, and (2) a member 104
which functions as a sink for the indicator solution. Encapsulation or other packaging is employed to prevent evaporation and to keep the indicator solution from being contaminated. Extending between these two components of detector 80 and along the side wall 106 of main casing member 84 with its opposite ends 108 and 110 respectively trained around reservoir capsule 102 and sink 104 is an elongated wick or reaction member 112. This wick is visible through a window 114 in casing member side wall 106. Window 114 may be provided by molding main casing member 84 from a clear plastic or by installing a window of such material in a casing member otherwise formed from a different material. Appropriate clear polymers are identified above and hereinafter.
Wick 112 will typically be fabricated from a conventional, commercially available, non-woven, Nylon paper. Other materials with wicking capabilities may instead be employed; but it is, however, important that the wicking medium not be acidic. Otherwise, it might affect a change in the indicator solution not attributable to the presence of a threshold level of carbon dioxide, consequently keeping the carbon dioxide detector from working properly. Member 104 can be made from an absorbent material such as a gauze sponge.
To employ detector 80, a lanyard 116 (see FIGS. 4 and 6) is pulled before the connection between detector 80 and endotracheal tube adapter 32 is effected. This ruptures reservoir 102 over a span indicated by reference character 118 in FIG. 4, allowing the indicator solution to flow onto and saturate that end 108 of wick 112 at reservoir 102.
If tracheal intubation of patient 24 has been achieved, carbon dioxide in the exhalations flowing through detector 80 in the direction indicated by arrow 120 in FIG. 4 will reversibly hydrate in the indicator solution migrating along wick 112 and effect an indicator color change as discussed above.
By virtue of the provision of sink 104, the indicator solution will migrate to the left .along wick 112 as indicated by arrow 122 once it has been released from reservoir 102, typically for a period of approximately fifteen minutes. If tracheal intubation has been achieved, the indicator on wick 112 will tend to revert to its original color between exhalations, a change promoted by air flowing through the detector to the patient and flushing carbon dioxide from the indicator solution as the air traverses detector casing 82. That part of the wick subsumed by the color change will increase with each successive exhalation. This clearly indicates that tracheal intubation has been achieved.
In contrast, if endotracheal tube 26 has instead been mistakenly placed in the patient's esophagus, the initial color change may be detected for each of, at most, a very few breaths. Thereafter, the indicator solution migrating across wick 112 will tend to revert to its original color and stay that color. Again, a distinct indication -- in this case of esophageal rather than tracheal intubation -- is afforded. In both cases, the discussed visual indications are clearly observable through the window 114 in casing member side wall 106.
An integral flow director 124 in housing 82 directs the gases into intimate contact with the indicator solution on wick 112 to promote the reversible hydration of carbon dioxide discussed above and, consequently, the ability of device 80 to detect carbon dioxide present in those gases.
Referring still to the drawing, FIGS. 7 and 8 depict yet another carbon dioxide detector 130 embodying the principles of the present invention. This detector resembles the carbon dioxide detector 34 illustrated in FIGS. 2-4 and discussed above. To the extent that this is true, like components of detectors 34 and 130 have been identified by the same reference characters.
The carbon dioxide detector 130 illustrated in FIGS. 7 and 8 is furthermore like detector 34 in that an indication commensurate with a threshold level of carbon dioxide having been reached in a sample being monitored is produced by: (1) that carbon dioxide diffusing across a permeable membrane and undergoing reversible hydration in an indicator solution behind the membrane, and (2) a consequent generation of an excess of hydrogen ions in the indicator solution to trigger a change in the color of the indicator.
Indicator 130, however, does differ in a major respect frcm indicator 34 in that the solute (dry components, typically a pH sensitive indicator and a carbonic anhydrase catalyst) and solvent (typically water plus a buffer) of the indicator solution are not mixed until carbon dioxide detector 130 is readied for use. As discussed above, this is important with respect to the storage life prior to use of the detector because the indicator solution will typically contain one or
more constituents which are much more stable in dry form then in aqueous solution.
In indicator 130, the typically but not necessarily aqueous, fluid phase of the indicator .solution is injected into the sealed cavity 62 behind permeable membrane 56 through injection port 74. The remaining constituents of the indicator solution are furnished in a dry form and placed in a compartment 132. This compartment lies between a seal 134 located in a depression 135 in the central section 50 of casing 42 and a flexible push tab 136 fixed to that seal. A communicating channel 138 is provided through detector housing 42 between sealed compartment 132 and the sealed cavity 62 behind membrane 56.
To ready carbon dioxide detector 130 for use, one presses down on tab 136 (i.e., in the direction indicated by arrow 140 in FIG. 8). This ruptures the seal 134 at the outer end of channel 138, providing fluid communication between the sealed cavity 62 housing the fluid phase of the indicator solution and the cavity 132 housing those components of the indicator solution stored in dry form. The clinician or other user of carbon dioxide detector 130 then shakes that device to mix the components of the indicator solution and thereby disperse the dry components in the liquid carrier. This results in color being developed in the indicator solution, clearly indicating to the user of the device that the liquid and solid components of the solution have been intimately mixed.
Thereafter, carbon dioxide detector 130 functions in the same manner as the detector 34 discussed above.
Referring again to the drawing, FIGS. 9-11 depict a novel carbon dioxide detector 144 which embodies the principles of the invention and which, like the detector 130 illustrated in FIGS. 7 and 8, is designed for increased shelf life.
Again, components of detector 144 which are like those of previously disclosed embodiments of the invention will be identified by the same reference characters. As in the case of carbon dioxide detector 130, detector 144 has an increased shelf life because constituents of the indicator solution such as the above-discussed carbonic anhydrase catalyst are stored in their most stable, dry form until the detector is readied for use.
Specifically, in detector 144, the deterioration susceptible component (or components) of the indicator solution are placed on a porous wick 146; and the remaining constituents of the indicator solution 148, including one of the indicators identified above or a comparable one, are confined in a capsule 150. This allows the protected material to be stored in more stable, dry form, thereby increasing the shelf life of the detector in which the protected material is employed.
Also, in carbon dioxide detector 144, an opening 152 is formed in the center section 50 of the detector housing or casing 42 (in this case generally ϋ-sectioned, see FIG. 11). Supported in this opening by integral flanges 154...157 (see FIGS. 9 and 10) in a tight fitting relationship to casing 42 is a membrane and wick support 158 with a bottom wall 160 (see, especially, FIG. 10). The flanges 154 and 156 of this
detector component are seated on end section 48 and shoulder 44 of detector casing 42 at the opposite ends of opening 152.
Membrane 56 is trapped against the bottom wall 160 of support 158 by a combined lens and actuator support 162. This component fits in a recess 164 in membrane/wick support 158 (see FIG. 10) and is frictionally retained in that recess.
An aperture 166 is formed through the center section 50 of detector casing 42 opposite membrane 56 . In a manner akin to that discussed above in conj unction with detectors 34 and 130 , this allows carbon dioxide in exhaled breaths or other gases traversing the bore 54 in detector casing 42 to flow into contact with, and migrate through, the permeable membrane.
The wick 146 which serves as a carrier or support for a carbonic anhydrase catalyst (or other "dry" phase) in the illustrated, representive embodiment of the invention is seated in, and extends at both ends beyond, a recess or enclosed space 168 opening onto the lower side 170 of the lens/actuator support 162 immediately adjacent membrane 56 . The membrane therefore traps wick 146 in recess 168. Wick 146 of detector 144 will typically be fabricated f rom a 2-4 mil thick, porous Nylon. Other materials may instead be used with the caveat that the material must facilitate the rapid migration of the indicator solution across the wick.
The capsule 150 containing the liquid or fluid phase of the indicator solution is fabricated from a thermoplastic polymer such as polyvinyl chloride . The capsules may conveniently be made by filling an elongated tube of the selected polymer with the
solution, heat sealing the tube from edge to edge at intervals therealong, and subsequently separating the thus provided, filled capsules.
Turning now to FIGS. 10 and 11, the lens/actuator support 162 has a vertically oriented, integral section 172 with a rectangularly sectioned cavity 174 extending from top to bottom thereof. A passage 176 in component 162 provides fluid communication between the bottom end of cavity 174 and that enclosed space 168 in component 162 which houses membrane 146.
Referring still to FIGS. 10 and 11, an integral, vertically extending pin 180 with a point or knife edge 182 at its upper end is formed in detector component 162 at the bottom of cavity 174. The indicator solution filled capsule 150 is installed in cavity 174 with the lower edge 184 of the capsule resting on the pointed, upper end 182 of pin 180.
A frictionally retained plunger 186 with an operator-engageable button 188 and an integral, depending main body section 190 configured to match the contour of cavity 174 is installed in the latter above the indicator solution-containing capsule 150. The capsule is seated in an arcuate recess 192 in the lower end of the plunger section with the plunger resting on the capsule 190 and thereby restrained against side-to-side movement in the cavity.
To ready detector 144 for use, plunger 186 is displaced by button 188 in the direction indicated by arrow 193 in FIG. 10 until detents 194 and 195 at the opposite sides of the plunger main section 190 click into cooperating recesses 196 and 197. These recesses are formed in vertically oriented, lens/plunger support
component 162 at the opposite sides 198 and 200 of the vertical, rectangularly sectioned cavity 174 in section of that component and toward the upper end of the cavity. As best shown in FIG. 11, the cavity surrounding end walls 202 and 204 of section 172 have recesses 206 and 208 at the upper ends thereof. These accommodate the opposite ends of button 188, allowing plunger 186 to move downwardly to the extent that detents 194 click into recesses 196. This movement of plunger 186 presses capsule 150 against the point 182 of pin 180 with sufficient force to rupture the capsule and force the indicator solution 148 in the capsule under pressure from cavity 174 through passage 176 into the enclosed space 168 housing wick 146. Consequently, the readying for use of carbon dioxide detector 144 does not require any particular orientation of the detector. This is a decided advantage, particularly under field conditions. As plunger 186 is moved downwardly by pressingon button 188 in the manner just described, the recessed lower end of the plunger keeps the capsule from being displaced to the side, thereby ensuring that it will be ruptured in the desired manner. The click stop arrangement discussed above is important in readying carbon dioxide detector 144 for use in that it provides a clear indication to the user that plunger 186 has been depressed to the extent sufficient to rupture capsule 150 in the manner just described.
Referring now particularly to FIG. 10, the fluid phase of the indicator solution released from capsule 150 by rupturing the latter and pumped through
the communicating passage 176 into the cavity 168 in which wick 146 is housed dissolves the "dry" indicator constituent or constituents on that wick as it migrates thereacross. Because of the wicking capabilities of support 146, this occurs within a few seconds, resulting in color being developed in the indicator solution. This development of color clearly indicates to the user of the device that the carrier supported and capsule contained components of the solution have been intimately mixed and that the carbon dioxide detector 144 is therefore ready for use.
In this regard, and as is best shown in FIG. 10, the opposite sides 212 and 214 of plunger main section 190 are relieved as with the illustrated, vertically extending slots 216 and 218. These slots allow air to escape from that part 220 of the cavity 174 in lens/plunger support component 162 beneath plunger 186 as the latter is depressed. This ensures that the plunger can readily be fully displaced to the click stop position discussed above.
At least the lens/plunger supporting component 162 of detector 144 is fabricated from a clear polymer and with an integral, convex lens 210 opposite indicator solution-filled space 168 (see FIGS. 9 and 10) so that the development of color in the indicator solution and subsequent changes in that color can be readily seen by the user of the device. This component of carbon dioxide detector 144, as well as the other components of that device, may be made from a number of clear, thermoformable polymers -- for example, the styrene-butadiene copolymers marketed by Phillips Petroleum Company under the trade name K-RESIN.
It is not essential, in fabricating a carbon dioxide detector of the type illustrated in FIGS. 9-11, that the carbonic anhydrase catalyst or other protected constituent or constituents of the indicator solution be supplied on a wick. Instead, the protected constituent or constituents may be deposited in the bottom end of indicator solution flow channel 176 on porous membrane 56 as indicated by reference character 222 in FIG. 11. This technique for placing the protected material is particularly appropriate in the case of substances such as carbonic anhydrase. That enzyme has a somewhat sticky nature in its "dry" form and will therefore readily adhere to the porous membrane and the wall of channel 176 and thereby remain in place. Carbon dioxide in the gases flowing through detector 144 reach porous membrane 56 through the opening 166 in casing central section 50 and migrate through permeable membrane 56 into the closed space 168 housing indicator solution 148. Thereafter, the carbon dioxide is reversibly hydrated in the indicator solution to produce excess hydrogen ions and lower the pH of the indicator solution. If the carbon dioxide is at, or reaches, a threshold level, the pH of the solution will decrease to a level capable of triggering an indicator color change and providing a visual indication that the concentration of carbon dioxide is at or has reached the threshold level.
In the typical application of the invention discussed herein -- the mechanical ventilation of an intubated patient -- the color change effecting reactions just discussed and the consequent color change will occur when the patients exhales. Subsequently, a carbon dioxide depleted mixture of gases will be pumped
to the patient through carbon dioxide detector 144. This results in a reduction of the partial pressure of the carbon dioxide reversibly hydrated in the indicator solution. That compound will consequently come out of solution, lowering the concentration of hydrogen ions in the solution and thereby increasing its pH to a level at which the indicator will revert to its original color. This provides a clear visual indication that the concentration of carbon dioxide in the gases flowing through carbon dioxide detector 144 has decreased to a level below the selected threshold level. As in the embodiments of the invention described previously, the continuance of the cyclic change of indicator color over a number of cycles, corresponding in duration to the breaths of an intubated patient, provides visual confirmation that tracheal intubation has been achieved.
In other applications of the invention, original and changed colors are clear visual indications of, respectively, the absence and presence of a threshold level of carbon dioxide in gases being sampled and passing through the bore 54 in carbon dioxide detector 144.
In a typical carbon dioxide detector of the character disclosed herein, the constituents of the indicator solution will be the following:
Dry Phase: Indicator (Cresol Purple) 100 mg Fluid Phase: Distilled Water 100 ml, 0.01M NaOH (buffer) 50 ml.
It is not required, in conjunction with the preceding example, that the carrier of the indicator solution be an aqueous one. For example, the reversible hydration of carbon dioxide in ethanol is a well-documented phenomenom. The use of this compound
and other fluids in which the reversible hydration of carbon dioxide can be carried out in the indicator solutions of the present invention is therefore intended to be covered in the appended claims unless expressly excluded therefrom.
Also, as was discussed above on more than one occasion, a catalyst -- preferably a "dry" carbonic anhydrase isozyme or a mixture of such isozymes -- can be added to the indicator solution to increase the speed with which the detector employing the indicator solution reacts to a change in carbon dioxide concentration. Storage of this catalyst and/or other perishable indicator solution constituents is optionally employed to increase the shelf life of the detector. As .indicated above and as will be apparent to those versed in the arts to which this specification is addressed, the foregoing, exemplary application of the invention (confirming tracheal intubation) is only one of many in which the principles of that invention can be employed to advantage. Other representative applications involve the monitoring of carbon dioxide levels in industrial processes and in enclosed working and/or living areas where accumulation of carbon dioxide can pose a hazard -- on board submarines, for example. Furthermore, the invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The embodiments of that invention discussed above are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing
description; and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Claims
1. A method of providing an indication that the level of carbon dioxide in a sample of gases containing that gas is at or has reached a threshold level and comprising the steps of: conveying said sample to a controlled environment in a detector where carbon dioxide can be reversibly hydrated to provide an excess of H+ ions and providing in said environment a solution of an indicator which will change character in the presence of a concentration of H+ ions capable of triggering the change in character and indicative of at least threshold concentration of carbon dioxide being present in said sample.
2. A method as defined in claim 1 wherein at least one constituent of the solution that tends to be unstable in said solution is stored separately in said dectector and apart from the fluid phase of the solution in a more stable form and is added to the solution in the course of readying said detector for use to thereby increase the shelf life of said detector.
3. A method as defined in claim 2 in which the separately stored constituent is an isozyme of carbonic anhydrase or a mixture of such isozymes for catalyzing the reversible hydration of said carbon dioxide.
4. A method as defined in claim 2 in which the detector has a casing and a membrane which is permeable to carbon dioxide and cooperates with a recess in said casing to form a sealed cavity, wherein the fluid phase of the indicator solution is put in said sealed cavity and the separately stored material is put in a compartment that is isolated from said cavity by a seal, and wherein said seal is ruptured and the separately stored material and the fluid phase of the indicator solution mixed in the course of readying said detector for use.
5. A method as defined in claim 2 in which the separately stored material is placed on a wick, the fluid phase is put in a capsule, the capsule is placed in a cavity in the detector which is in fluid communication with the wick, and said detector is readied for use by cupturing said capsule and allowing said fluid phase to reach and migrate across said wick and thereby incorporate the separately stored material in the indicator solution.
6. A method as defined in claim 5 which includes the step of forcing the fluid phase of the solution under pressure from the ruptured capsule to said wick.
7. A method as defined in claim 1 which includes the step of buffering said solution as to alter that concentration of carbon dioxide required to effect the change in character of the indicator.
8. A method as defined in claim 7 wherein the indicator solution is buffered with a mixture of scdium barbital and hydrochloric acid, or with sodium bicarbonate, or with sodium hydroxide.
9. A method as defined in claim 1 which includes the step of incorporating a catalyst in said solution to reduce the time required for said indicator to undergo said change in said character and the time for .said indicator to revert to its original state once the concentration of carbon dioxide in said controlled environment decreases to a level below said threshold level.
10. A method as defined in claim 9 in which the catalyst is one of the following: Carbonic Anhydrase, NaOCl,
Na Selenite, or Na2SO3.
11. A method as defined in claim 10 wherein the catalyst is an isozyme of carbonic anhydrase or a mixture of such isozymes.
12. A method as defined in claim 11 which includes the step of adding a stabilizer and/or a preservative for the carbonic anhydrase to the indicator solution.
13. A method as defined in claim 12 wherein: (a) the stabilizer, if employed, is glycerol or propylene glycol, and (b) the preservative, if employed, is a paraben.
14. A method as defined in claim 1 in which the indicator solution is applied to a wick and in which the gases are circulated into contact with said wick.
15. A method as defined in any of the preceding claims 1-13 and employed to ensure that an airway tube is placed in the trachea of a patient, said method comprising the steps of: directing gases discharged from said tube into said controlled environment, providing in said environment an indicator as aforesaid which will undergo a change in character only if the level of carbon dioxide in said gases is consistent with tracheal intubation, and observing whether .said change in character has occurred in each of a series of exhalations by the patient, it being the occurrence of said change of character coincident with each of said exhalations that is employed as an indication of tracheal intubation.
16. A method as defined in claim 15 which includes the step of flushing carbon dioxide from said controlled environment between exli-alations to promote the tendency of the indicator to revert to its original color between exhalations.
17. A method as defined in claim 15 which includes the step of causing the indicator solution to migrate across a reaction member to a sink and wherein it is the appearance of said changed character across successive segments of the reaction member with a frequency approximating the breathing rate of the patient that is employed as an indication that trachea intubation has been achieved.
18. A carbon dioxide detector comprising:
(a) a reaction chamber; and
(b) a solution of a pH sensitive indicator in which carbon dioxide circulated to said chamber can be reversibly hydrated to produce an excess of H+ ions and thereby effect a pH change of sufficient magnitude to effect a discernible change in said indicator if the concentration of carbon dioxide in the reaction chamber is at or rises to a level at which said pH is lowered to the level at which the change in said indicator will be effected.
19. A carbon dioxide detector as defined in claim 18 which has: (c) a first storage means for the solvent phase of the indicator solution;
(d) a second, separate, storage means for a perishable constituent of the solution; (e) means for providing fluid communication between the first and second storage means; and
(f) a seal providing isolation between said first and second storage means, whereby the perishable constituent of said indicator solution can be isolated from the solvent phase to promote a long storage life until said detector is readied for use by rupturing said seal to enable said fluid communication means and thereby allow said solvent phase to contact and be mixed with said perishable constituent.
20. A carbon dioxide detector as defined in claim 19 which has a flexible tab cooperating with said seal to define said second storage means, said tab being: (a) accessible from the exterior of the detector, and (b) manually displaceable to press the contents of said second storage means against and thereby rupture said seal.
21. A carbon dioxide detector as defined in claim 19 which has a housing with a flow passage therethrough and a membrane that is permeable to carbon dioxide bounding and surrounding said flow passage and cooperating with said housing to define said first storage means.
22. A carbon dioxide detector as defined in claim 21 which has a channel extending from said first storage means through said housing to the exterior of the housing, wherein said seal overlies that end of the channel opening onto the exterior of the housing, and wherein said flexible tab overlies and is fixed to said seal.
23. A carbon dioxide detector as defined in claim 19 wherein said second storage means compri.ses a wick on which the perishable constituent is placed.
24. A carbon dioxide detector as defined in claim 23 which has a housing and means cooperating with said housing to provide a sealed space housing said wick and containing the indicator solution, said cooperating means including a membrane for isolating said indicator solution from gases flowing thereto from the detector and said membrane being permeable to carbon dioxide but impermeable to charged molecules and ions.
25. A carbon dioxide detector as defined in claim 24 wherein said membrane bounds and surrounds a flow passage through the detector.
26. A carbon dioxide detector as defined in claim 19 wherein said first storage means is a cavity that is adapted to receive a capsule filled with the fluid phase of the solution.
27. A carbon dioxide detector as defined in claim 26 in which the capsule both defines the first storage means and provides the seal between the first and second storage means.
28. A carbon dioxide detector as defined in claim 26 which has a housing and means cooperating with said housing means to provide a sealed space housing said wick and containing the indicator solution and wherein said fluid communication means is a passage extending from said cavity to said sealed space at one end of said wick.
29. A carbon dioxide detector as defined in claim 26 which has a housing and means cooperating with said housing means to provide a sealed space housing said wick and containing the indicator solution and means opposite said sealed space through which color changes in the indicator solution in said sealed space can be observed.
30. A carbon dioxide detector as defined in claim 26 which has a means for promoting the rupture of said capsule, said means being located in said cavity and said detector further comprising plunger means which can be so displaced as to press said capsule against the means located in the cavity and thereby rupture said capsule.
31. A carbon dioxide detector as defined in claim 30 which has means for providing to a user an indication that said plunger has been depressed to an extent adequate to rupture the capsule.
32. A carbon dioxide detector as defined in claim 30 wherein said second storage means is a wick on which said perishable constituent can be placed and wherein the detector has a housing with a flow passage therethrough and a recess therein, a support seated in said recess, means cooperating with said support to provide a sealed space housing said wick and containing the indicator solution, and a membrane for retaining said wick in said space and isolating said indicator solution from gases flowing through said flow passage, said membrane being permeable to carbon dioxide but impermeable to charged molecules and ions, and there being an opening in said support through which gases flowing through said detector can reach said membrane.
33. A carbon dioxide detector as defined in claim 32 which has means opposite said sealed space through which color changes in the indicator solution in said sealed space can be observed; means for promoting the rupture of said capsule, said means being located in said cavity; plunger support means; and means which can be so displaced relative to the plunger support means as to press said capsule against the rupture promoting means located in the cavity and thereby rupture said capsule; the means through which changes in the color of the indicator solution can be viewed and the plunger support means being incorporated into a single component, there being a recess in the support component, and said single component being seated in said support component.
34. A carbon dioxide detector as defined in claim 18 which includes structural means having a first compartment for the solvent phase of the indicator solution; a second, communicating compartment for the solute phase of said solution; and a rupturable seal between said first and second compartments, whereby the solute phase of said indicator solution can be isolated from the solvent phase to promote a long storage life until said detector is readied for use by rupturing said seal and thereby allowing said solute phase to be mixed with said solvent phase.
35. A carbon dioxide detector as defined in claim 18 which includes a sealed reservoir containing said indicator solution and a reaction member across which said solution can migrate, one end of said reaction member being at said reservoir and there being a sink at the opposite end of the reaction member for promoting the migration of the indicator solution across the reaction member.
36. A carbon dioxide detector as defined in claim 35 which includes means which is activatable to rupture said reservoir and thereby release the indicator solution from the reservoir and make it available for migration across said reaction member.
37. A carbon dioxide detector as defined in claim 35 which includes a housing having therein spaced apart cavities in which the reservoir and sick are installed and a wall between the cavities along which the reaction member is trained, there being a window in said wall through which changes in the character of said indicator can be seen.
38. A carbon dioxide detector as defined in claim 35 which includes a housing for said reservoir, said reaction member and said sink, said housing including one member in which said components are installed and a lid that can be sealed to said one housing member to isolate the interior of the housing from the ambient surroundings and thereby prevent contamination of the indicator migrating along the reaction member.
39. A carbon dioxide detector as defined in claim 35 which includes a housing for said reservoir, said wick, and said sink and wherein there are an inlet to and an outlet from said housing and means in said housing for directing gases flowing from said inlet to outlet into contact with the indicator solution on the reaction medium.
40. A carbon dioxide detector as defined in claim 39 which comprises first and second bosses at the opposite end of said housing, said-bosses having passages therethrough which respectively communicate with said inlet and said outlet and there being means in said first boss and on said second boss for making connections to a ventilator hose and to an endotracheal tube.
41. A carbon dioxide detector as defined in claim 18 wherein said change in character is a change in color and wherein the detector has a housing in part defining the reaction chamber and means on said housing at opposite ends of the reaction chamber which identify by color matching with the indicator whether or not carbon dioxide is present in the gases being monitored in a concentration sufficiently high to effect said color change.
42. A carbon dioxide detector as defined in claim 19 which has a casing with a flow passage extending therethrough and casing-associated means at one end of said passage to which an endotracheal tube can be attached, thereby making said detector capable of determining whether said endotracheal tube has been properly placed in the trachea of a patient in that said indicator change will be effected only if the gases discharged from said tube and flowing through said detector passage have a carbon dioxide concentration consistent with tracheal intubation.
43. A carbon dioxide detector as defined in claim 18 which includes:
(a) housing having a central section with a flow passage extending therethrough;
(b) first and second bosses at the opposite ends of and aligned with said housing central section, said bosses having flow passages therethrough which communicate with the flow passage through said housing central section and through which gases f rom said specified environment can be delivered to and carried away from opposite ends of said central section flow passage;
(c) means comprising a membrane that is permeable to carbon dioxide and bounds and surround the flow passage through said housing central section and cooperates with said housing central section to form a sealed cavity for the indicator means; and
(d) means in said housing central section through which said indicator solution can be introduced into said sealed cavity.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16086388A | 1988-02-26 | 1988-02-26 | |
US160,863 | 1988-02-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1989007956A1 true WO1989007956A1 (en) | 1989-09-08 |
Family
ID=22578784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1989/000760 WO1989007956A1 (en) | 1988-02-26 | 1989-02-24 | Carbon dioxide detection |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0445111A1 (en) |
AU (1) | AU3347189A (en) |
WO (1) | WO1989007956A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5279289A (en) * | 1991-10-15 | 1994-01-18 | Kirk Gilbert M | Resuscitator regulator with carbon dioxide detector |
US5375592A (en) * | 1993-04-08 | 1994-12-27 | Kirk; Gilbert M. | Carbon dioxide detector and shield |
WO1997014464A1 (en) * | 1995-10-20 | 1997-04-24 | Nellcor Puritan Bennett Incorporated | Pediatric endotracheal apparatus |
FR2782646A1 (en) | 1998-09-02 | 2000-03-03 | Smiths Industries Plc | BREATHING APPARATUS HAVING AN INDICATOR ASSEMBLY |
US6123075A (en) * | 1991-10-15 | 2000-09-26 | Mallinckrodt, Inc. | Resuscitator regulator with carbon dioxide detector |
EP1421901A2 (en) * | 2002-11-20 | 2004-05-26 | Maquet Critical Care AB | Arrangement for passive gas sampling |
US6877512B2 (en) * | 2001-09-05 | 2005-04-12 | The Regents Of The University Of California | Airway device |
WO2008003928A1 (en) | 2006-07-04 | 2008-01-10 | Smiths Group Plc | Respiratory assembly including a carbon dioxide detector |
US10398869B2 (en) * | 2015-02-16 | 2019-09-03 | Babak KHABIRI | Oxygen delivery and ventilation monitoring systems |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3114610A (en) * | 1961-05-17 | 1963-12-17 | Martin Marietta Corp | Continuous sampling gas analyzer |
US4728499A (en) * | 1986-08-13 | 1988-03-01 | Fehder Carl G | Carbon dioxide indicator device |
-
1989
- 1989-02-24 AU AU33471/89A patent/AU3347189A/en not_active Abandoned
- 1989-02-24 WO PCT/US1989/000760 patent/WO1989007956A1/en not_active Application Discontinuation
- 1989-02-24 EP EP89903316A patent/EP0445111A1/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3114610A (en) * | 1961-05-17 | 1963-12-17 | Martin Marietta Corp | Continuous sampling gas analyzer |
US4728499A (en) * | 1986-08-13 | 1988-03-01 | Fehder Carl G | Carbon dioxide indicator device |
Non-Patent Citations (1)
Title |
---|
See also references of EP0445111A4 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5279289A (en) * | 1991-10-15 | 1994-01-18 | Kirk Gilbert M | Resuscitator regulator with carbon dioxide detector |
US5456249A (en) * | 1991-10-15 | 1995-10-10 | Kirk; Gilbert M. | Resuscitator with carbon dioxide detector |
US5679884A (en) * | 1991-10-15 | 1997-10-21 | Kirk; Gilbert M. | Resuscitator with carbon dioxide detector |
US6427687B1 (en) | 1991-10-15 | 2002-08-06 | Mallinckrodt, Inc. | Resuscitator regulator with carbon dioxide detector |
US6123075A (en) * | 1991-10-15 | 2000-09-26 | Mallinckrodt, Inc. | Resuscitator regulator with carbon dioxide detector |
US5375592A (en) * | 1993-04-08 | 1994-12-27 | Kirk; Gilbert M. | Carbon dioxide detector and shield |
US5517985A (en) * | 1993-04-08 | 1996-05-21 | Kirk; Gilbert M. | Carbon dioxide detector and shield |
WO1997014464A1 (en) * | 1995-10-20 | 1997-04-24 | Nellcor Puritan Bennett Incorporated | Pediatric endotracheal apparatus |
US6378522B1 (en) | 1998-09-02 | 2002-04-30 | Smiths Industries Public Limited | Respiration assemblies and indicators |
FR2782646A1 (en) | 1998-09-02 | 2000-03-03 | Smiths Industries Plc | BREATHING APPARATUS HAVING AN INDICATOR ASSEMBLY |
US6877512B2 (en) * | 2001-09-05 | 2005-04-12 | The Regents Of The University Of California | Airway device |
EP1421901A2 (en) * | 2002-11-20 | 2004-05-26 | Maquet Critical Care AB | Arrangement for passive gas sampling |
EP1421901A3 (en) * | 2002-11-20 | 2004-08-11 | Maquet Critical Care AB | Arrangement for passive gas sampling |
WO2008003928A1 (en) | 2006-07-04 | 2008-01-10 | Smiths Group Plc | Respiratory assembly including a carbon dioxide detector |
US8534288B2 (en) | 2006-07-04 | 2013-09-17 | Smiths Group Plc | Detectors |
US10398869B2 (en) * | 2015-02-16 | 2019-09-03 | Babak KHABIRI | Oxygen delivery and ventilation monitoring systems |
Also Published As
Publication number | Publication date |
---|---|
AU3347189A (en) | 1989-09-22 |
EP0445111A1 (en) | 1991-09-11 |
EP0445111A4 (en) | 1994-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5291879A (en) | Carbon dioxide detection (II) | |
US4790327A (en) | Endotracheal intubation device | |
US4945918A (en) | Method and apparatus for monitoring a patient's circulatory status | |
US5517985A (en) | Carbon dioxide detector and shield | |
US5857460A (en) | Gas-sensing mask | |
US10420906B2 (en) | Airway products and technique for using the same | |
US4928687A (en) | CO2 diagnostic monitor | |
Goldberg et al. | Colorimetric end-tidal carbon dioxide monitoring for tracheal intubation | |
CA1286958C (en) | Carbon dioxide detector | |
US7992561B2 (en) | Carbon dioxide-sensing airway products and technique for using the same | |
US5156159A (en) | CO2 diagnostic monitor with rupturable container | |
JPS62236559A (en) | Intratracheal instrument | |
WO1994000756A1 (en) | A device for indicating the presence of carbon dioxide in a patient's exhaled air | |
WO1989007956A1 (en) | Carbon dioxide detection | |
Walker et al. | Breathing circuits | |
GB2379612A (en) | Face mask with respiratory gas tester | |
Casati et al. | Arterial to end-tidal carbon dioxide tension difference in anaesthetized adults mechanically ventilated via a laryngeal mask or a cuffed oropharyngeal airway | |
Letheren | A case of hyponatremia while using ethanol labeling for endometrial resection | |
Rosenberg et al. | A simple, disposable end-tidal carbon dioxide detector. | |
CN110339446A (en) | A kind of tracheal catheter convenient for positioning | |
Lampotang et al. | CO 2 diagnostic monitor with rupturable container | |
Pennant et al. | The Laryngeal Mask Airway and Laryngeal Polyposis | |
McKenna | The Laryngeal Mask Airway and Laryngeal Polyposis | |
Lampotang et al. | CO 2 diagnostic monitor | |
EP1680015A1 (en) | Diagnostic probe and kit for tonometric examination of respiratory insufficiency and regional perfusion failure of the body |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR DK JP NO |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1989903316 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1989903316 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1989903316 Country of ref document: EP |